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ABSTRACT
There are many contradictory reports in the literature involving the culture of Spiroplasma
mirum, its resistance to disinfectants and antibiotics, and its potential role in Transmissible
Spongiform Encephalopathies (TSEs). These contradictions led to an interest in a possible link
between spiroplasma and TSEs and the development of a research plan to elucidate this
connection. It was hypothesized that Spiroplasma was associated with a neurodegenerative
disease such as TSE. In this work we further characterized S. mirum laboratory strains and
continued to evaluate the possible correlations they have with TSE infections and the prion.
To optimize recovery of S. mirum from experimental infections, we established reproducible
culture conditions in M1D media, embryonated eggs, and SP4 plates. Overall, results indicated
that SP4 plates are the most accurate quantitative method for S. mirum. However, plate counts
should be accompanied by qualitative assessments of cultures in liquid M1D as well.
A susceptibility profile for physical and environmental disinfectants and antibiotics for
spiroplasma was also determined. The three species of Spiroplasma tested were susceptible to
minimal dilutions of common laboratory disinfectants. They were also susceptible to many of
the antibiotics in use for other mollicutes. Although Spiroplasma and prions, the presumed
infectious agent of TSEs, may both persist in neurologic tissues for extended periods of time, the
two do not share the same properties of resistance.
Experimental neonatal goat infections with a S. mirum laboratory strain SMCA using three
different inoculation routes did not result in pathology, clinical signs, or an immune response
over a two year time period. In addition, the organism was not detected via PCR or culture. The
same strain did cause minimal clinical signs in one animal when inoculated into five month old
white-tailed deer and was recovered from the cortex of the clinically-affected deer after multiple
passages in culture. Although the goat experiments did not result in TSE-like disease, an
improved methodology for a spiroplasmosis animal model was developed, and further research
should be conducted using similar methods in neonatal white-tailed deer.
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CHAPTER 1: INTRODUCTION/ REVIEW OF LITERATURE
Introduction
Mollicutes are the smallest known self-replicating organisms. Classified by their genome size,
sterol requirement, morphology, urea utilization, and other biochemical properties, they are
divided into five genera: Acholeplasma, Anaeroplasma, Mycoplasma, Spiroplasma and
Ureaplasma (Murray and Schleifer, 1994). This group of organisms is believed to have resulted
from degenerative evolution of Gram-positive bacteria (Davis et al., 1972; Woese et al., 1980).
The members of the genus Spiroplasma were first recognized as helical, wall less bacteria in
1972 (Davis et al., 1972). Taxonomically, spiroplasmas are in the Domain Bacteria, Phylum
Firmicutes, Class Mollicutes, Order Entomoplasmatales, Family Sprioplasmataceae, and Genus
Spiroplasma. They received their name from a description of their motility in 1973 (Davis et al.,
1972). The first named spiroplasma was Spiroplasma citri, the causative agent of citrus stubborn
disease, which was originally considered a virus (Saglio et al., 1973). The Suckling Mouse
Cataract Agent (SMCA), isolated from rabbit ticks, was originally considered a virus because it
was filtered through such a small pore size (Clark, 1964). Spiroplasmas have also been
misidentified as spirochetes because of their similar appearance in dark field microscopy. The
sex ratio organism, SRO, which causes a disease fatal to only males of certain Drosophila
species, was originally considered a spirochete in 1961 but was later identified as a spiroplasma
(Williamson et al., 1983).
Spiroplasma were classified as Mollicutes (renamed from mycoplasma) because they form “fried
egg colonies” on solid media, pass through 0.22µm pore filters, fail to revert to walled bacteria,
are completely resistant to penicillin, and lack cell wall or murien cell wall precursors (Bove,
1984a; Saglio et al., 1973). When first defined, spiroplasmas were classified by G+C content,
their ability to utilize glucose and arginine, their host/habitat, serological tests, metabolism
inhibition, and spiroplasma deformation tests (Whitcomb, 1981). As more isolates were
characterized, serological cross reactions were helpful in establishing groupings; however, the
results needed to be duplicated in the deformation and metabolism inhibition tests in order to
fully establish a connection within a group (Whitcomb et al., 1983). Williams, et al. suggested
that as a last criterion, DNA-DNA homology should be used to determine an isolate’s grouping
into a single species (Davis et al., 1979; Williamson and Tully, 1982; Williamson et al., 1998).
In 2007 the requirements were made more stringent to prevent inaccurate classifications.
Currently the major requirements for placement to order and family include: tests for sterol
requirements, lack of cell wall as shown by transmission electron microscopy, ability to form
colonies on solid media, quantification of the ability to pass a graded series of ultra filters,
demonstration of the ability of the organism to grow at various temperatures with determination
of an approximate optimal temperature, determination of the base composition of organismal
DNA, and demonstration of antigenic relationships by using the spiroplasma deformation and
metabolism inhibition tests (Whitcomb, 2007). To date, Spiroplasmas have been classified into
34 groups and 14 subgroups (Padovan et al., 2000 ; Pettersson et al., 1996; Williamson et al.,
1998). Thirty-six representative members of these groups or subgroups have been described as
species.
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Spiroplasmas have a variety of hosts including plants and arthropods. There are three pathogenic
plant spiroplasmas: S. citri, S. kunkelii and S. phoeniceum, which are all found within group I.
These plant pathogens are most commonly found within plant phloem and flower nectar.
Spiroplasma melliferum, a honeybee pathogen not pathogenic to plants, is also a member of
group I (subgroup 1-2) and is closely related to the three pathogenic plant spiroplasmas. The
other four spiroplasmas in this group are either plant surface- or arthropod-associated organisms.
Plant surface spiroplasmas are thought to be deposited by insects, which are the major hosts of
members of groups II to XXXIV (Williamson et al., 1998). Spiroplasmas residing in arthropods
are transmitted to plant surfaces by defecation and/or regurgitation of fluids on plant surfaces or
may be introduced into the phloem by plant-sucking insects (Gasparich, 2002).
All members of the genus Spiroplasma are obligately associated with insects, either as
commensals, pathogens or mutualists (Gasparich, 2002). Most insect spiroplasmas are found
within the following orders: Hymenoptera (bees and wasps), Diptera (flies, horseflies, fruit flies,
mosquitoes), Coleoptera (beetles), Lepidoptera (butterflies), Homoptera (leafhoppers),
Hemiptera (green leaf bugs), or Odonta (dragonflies) (Tully and Whitcomb, 1991; Williamson et
al., 1997). Spiroplasmas are most commonly found in the gut, less frequently in the hemolymph,
and occasionally in salivary glands and other organs (Bove, 1997). In some insects, spiroplasmas
that are ingested may be highly invasive and pathogenic or lethal to the host. In addition to S.
melliferum, lethal infections in honeybees were also observed following exposure to S. apis
(Tully and Whitcomb, 1991). S. poulsonii is associated with sex ratio abnormalities in the
progeny of Drosophila spp. (Williamson et al., 1999), and S. floricola is associated with a
lethargy disease of the scarabaeid beetle Melolontha melolontha (Seemuller et al., 2002).
Spiroplasmas were also isolated from blood sucking insects such as mosquitoes and tabanid flies
(Tully and Whitcomb, 1991; Williamson et al., 1998).
Spiroplasmas have also been isolated from ticks and rabbit ticks have yielded two spiroplasmas:
S. mirum (SMCA, GT48, and TP-2) and Spiroplasma sp. strain 277F (Tully et al., 1982b).
SMCA causes cataracts and persistent neurological infections in a variety of small mammals
when inoculated intracerebrally (Clark, 1964). GT48 causes encephalitis when inoculated
intracerebrally and cataracts in experimental intraperitoneal inoculated rat infections (Bastian et
al., 1984; Tully et al., 1984). Spiroplasma sp. strain 277F caused mortality within three days
after intracerebral inoculation in suckling rats. Similar experiments with diluted cultures did not
produce any clinical or pathological changes. Strain 277F was not recovered from any
experimental animals (Stalheim et al., 1978). Eight serologically related isolates were also
isolated from an ixodes tick. A representative strain Y32 was characterized and designated S.
ixodetis (Tully et al., 1995).
Recently a spiroplasma has been implicated as the causative agent of tremor disease (TD) that
affects the central and surrounding nerve systems of the Chinese mitten crabs, Eriocheir sinensis
(Wang et al., 2004). This disease has had disastrous effects on aquaculture in China (Wei, 1999).
Based on morphological and pathological studies (Wang and Gu, 2002; Wang et al., 2002;
Zhang et al., 2000), the TD agent (TDA) was previously thought to be a rickettsia-like organism.
Analysis using universal primers for bacterial 16S rRNA gene sequences, however, showed that
the agent was not a rickettsia but a spiroplasma, showing 98% 16S rRNA gene sequence
similarity to S. mirum (Wang et al., 2003; Wang et al., 2004). Spiroplasma has also been isolated

2

from the American crayfish (Procambarus clarkii) and freshwater-cultured Pacific white shrimp
(Litopenaeus vannamei) in provinces of China (Wang et al., 2005). It was also associated with
mortalities in Pacific white shrimp of South America (Nunan et al., 2005; Nunan et al., 2004).
The report of a spiroplasma in a fresh water species has changed the understanding of this
organisms host range (Regassa and Gasparich, 2006).
Spiroplasma is a difficult organism to cultivate and isolate, adding to the classification
difficulties. Initially media was made for cultivation of spiroplasma with ingredients similar to
plant phloem (Saglio et al., 1973). As more spiroplasmas were identified from different hosts,
media began to reflect insect hemolymph (Tully et al., 1977). Most medias now contain 10-20%
fetal bovine serum, PPLO broth base and/or peptone and tryptone supplements, tissue culture
medium such as CMRL-1066 or Schneider’s Drosophila media, carbohydrates, fresh yeast
extract, and yeastolate (Whitcomb, 1981).
The first formulation for Spiroplasma growth was similar to mycoplasma media with the
addition of soribitol, fructose, sucrose and DNA (Whitcomb, 1981). Researchers were able to
characterize S. citri using mycoplasma media but ran into difficulties characterizing a similar
spiroplasma, the corn stunt spiroplasma (Saglio et al., 1971; Saglio et al., 1973). This led to the
formation of more complex media. M1 medium was designed to be a very rich media and with
slight variations has supported all spiroplasmas to date. The SP-4 medium used CMRL-1066
tissue culture supplement and was hypothesized to be best for those Spiroplasma with possible
vertebrate affinities (Whitcomb, 1981). This formulation was used to cultivate SMCA (Tully et
al., 1976). Table 1.1 lists the ingredients found in the most common spiroplasma media.
Mycoplasma medium was originally used for characterizing spiroplasma isolates. As research
developed, M1A use resulted in better growth for insect/flower isolates. The addition of yeast
extract was made for M1D media, which allowed for better growth for some spiroplasma isolates
and SP4 was developed for the tick isolates.
The literature has ample evidence that spiroplasma may be isolated from a variety of different
hosts. However, the isolation methods are tedious depending on the inoculum (Whitcomb,
1981). Isolating the corn stunt spiroplasma (CSS) required blind passage of sap-inoculated
cultures in contrast to easy primary isolation from infected maize (Jones et al., 1977). The
formulation of media also proved to be a critical factor in primary isolation. Jones demonstrated
that components of M1A medium are factors that allow for primary isolation of CSS from insect
hemolymph in contrast to attempts with SP-4 (Jones et al., 1977). Similarly, the isolation of
SMCA was more readily observed in SP-4 rather than M1A medium (Tully et al., 1981).
Research showed that different formulations are best for isolation and maintenance (Chen and
Davis, 1979; Chen and Granados, 1970). SRO is easily maintained in M1A, but attempts at
primary isolation in the same media were futile (Williamson and Poulson, 1979).
The research presented throughout this work will focus on S. citri, S. mirum, and S. melliferum.
Spiroplasma citri, a flower pathogen, was the first spiroplasma identified and fully characterized.
Spiroplasma mirum, isolated from ticks, was shown to be pathogenic to vertebrates.
Spiroplasma melliferum, an insect pathogen, is associated with pathology leading to death in
honey bees and has also been shown to multiply in vertebrates (LeGoff and Humphery-Smith,
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1991). Table 1.2 summarizes the host and pathology seen with these three species (Williamson
et al., 1998).

Table 1.1 Spiroplasma media (yields 300 mLs)
Ingredients
Standard Mycoplasma Medium M1A
M1D
SP4
Autoclave at 15psi for 30min
Mycoplasma broth
4.5 g
2.1 g
1g
base
Bacto-Tryptone
1g
3g
Bacto-Peptone
0.8 g
1.6 g
Glucose
0.1 g
Fructose
0.1 g
Sucrose
1g
Sorbitol
7g
Distilled water
200 mL
70 mL
197 mL
For solid media
Add 1.6 g Difco Noble Agar to
Add 2.4 g to 6.8 g Difco Noble
autoclavable portion
agar to autoclavable portion
Sterile filter
Schneiders Drosophilia
160 mL
medium
CMRL-1066 (10x
15 mL
w/glutamine, w/out
NaHCO3)
Fetal Bovine Serum
50 mL
50 mL
Horse Serum
60 mL
Fresh yeast extract
30 mL
10 mL 30 mL
(25%)
Phenol Red 0.5%
(0.1 %) 6mL
1.2 mL
1.2 mL
Potassium Penicillin
1.5 mL
2.5 mL
3 mL
(100,000 U/ml)
Yeastolate 2%
30 mL
Glucose (50% solution) 3 mL
3 mL
L-arginine-HCl 42%
1.5 mL

Table 1.2 Summary of differences seen in separate species of Spiroplasmas.
Identification Organism
Group Isolation method
Media Pathology
Date
1973
S. citri
I-1
Mycoplasma broth M1D Citrus stubborn disease
1982
S. mirum
V
Embryonated eggs SP4
Cataracts in suckling mice,
spongiform encephalopathy
1985
S. melliferum I-2
M1D broth
M1D Death in honey bees
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Spiroplasma citri
Host(s): Spiroplasma citri, known for its economic impact on citrus plants as the causative agent
of citrus stubborn disease, can infect a wide variety of woody and herbaceous hosts (Whitcomb,
1980). It is restricted to the phloem sieve tubes and is transmitted by phloem sap-feeding insects
(Bove et al., 2003). Spiroplasma citri is naturally transmitted by leafhoppers: Circulifer tenellus,
Scaphytopius nitrides and S. acutus delongi in California (Oldfield, 1988); Neoaliturus
haemactoceps (Bove et al., 1987) and C. tenellus (Klein et al., 1988) in the Mediterranean area.
Other insects may acquire the spiroplasma but do not transmit it (Bove and Saillard, 1979; Rana
et al., 1975). Spiroplasma citri is dependent on insect vectors for transmission and therefore the
distribution follows the patterns of the leafhoppers’ movements (Golino and Oldfield, 1990).
Isolation: Spiroplasma citri was isolated in 1971 from a Washington naval sweet orange tree
afflicted with stubborn disease (Bove and Saillard, 1979). Stubborn disease was described in
1944, and the causative agent was assumed to be a virus until this observation (Bove, 1984b).
Media: Spiroplasma citri was originally isolated in a moderately simple mycoplasma medium
(see Table 1.1) (Whitcomb, 1983). It is now most commonly cultivated in M1D medium. It has
a temperature range of 20oC - 37oC with 32oC being optimal and a 4.1 hour doubling time
(Konai et al., 1996).
Disease/Pathology: In the leafhopper, S. citri adheres to receptors within the gut and are taken
into the cytoplasm by endocytosis. After migrating through the cell, it is released by exocytosis
into the hemolymph, where it circulates and replicates. Spiroplasma citri is then transported
from the hemolymph to the saliva by passing through the basal lamina and adhering to receptors
on the plasmalemma outer surface, after which the spiroplasma are endocytosed, passed through
the cell, and exocytosed into the salivary ducts. From the ducts, they are introduced into the
phloem of plants with the saliva of feeding leafhoppers. The latency period in the insect is at
least two weeks (Liu et al., 1983).
Once in the plants, S. citri remains restricted to the phloem tissue where it spreads in the plant. It
causes severe symptoms, such as stunting, yellowing of leaves, and yield losses, in a variety of
economically important crops: grapefruits, lemons, mandarins, and oranges (Calavan, 1980).
The spiroplasma develops best in citrus under hot conditions (28oC - 32oC) and may not give rise
to symptoms at lower temperatures (Bove, 1988). These organisms are not transmitted via plant
seeds and are not transovarially transmitted to next-generation leafhoppers. Therefore, they
cannot survive outside their hosts and are dependent upon transmission for survival and dispersal
(Gasparich, 2002).
Other information: Spiroplasma citri utilizes three sugars: glucose and fructose, presumably
from the sieve tubes of the plant, and trehalose from the insect hemolymph (Bove et al., 2003).
At least two mechanisms are utilized for sugar uptake by S. citri: the
phosphoenolpyruvate:phosphotransferase system (PTS) and the SBP-ABC transporter system
(Bai and Hogenhout, 2002; Gaurivaud et al., 2000a). This could be characteristic of multiplehost bacteria that need to rapidly adapt from a host or host-compartment that uses one sugar to a
host or host-compartment that uses a different sugar (Bove et al., 2003). The identification of
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these systems within the spiroplasma genome may serve to determine the different hosts that
other isolates might inhabit.
Spiroplasma melliferum
Host(s): Spiroplasma melliferum, the first spiroplasma to be isolated from an insect, was
originally isolated from honey bees in Maryland in 1976 (Whitcomb, 1980). The organism has
also been isolated from bumble bees, andrenids, anthophors, robber flies, and one butterfly
species (Clark et al., 1985).
Isolation: In 1976, Clark isolated S. melliferum from diseased honey bees, Apis mellifera, in
Maryland (Clark, 1978) in M1D.
Media: Spiroplasma melliferum growth is supported well in M1D medium. It has a temperature
range of 20 - 41oC with 37oC being its optimal temperature with a 1.5 hour doubling time (Konai
et al., 1996).
Disease/Pathology: Spiroplasma melliferum is able to cross the gut barrier of the honey bee,
replicates at high numbers within the hemolymph and eventually kills its host (Bove, 1997).
Spiroplasma melliferum-infected bees frequently exhibit neurological signs (Clark, 1978). It can
be found on flower surfaces that are frequented by infected honey bees (Whitcomb, 1981) but
only causes fatality in the bee.
Spiroplasma melliferum also persists in suckling mice post-intracerebral inoculation.
Spiroplasma was found within the brain at high titers at 70 days post-inoculation and had limited
recovery 285 days post inoculation (LeGoff and Humphery-Smith, 1991).
Spiroplasma mirum
Host(s): Spiroplasma mirum was isolated from Haemaphysalis leporis-palustris, a rabbit tick
(Clark, 1964). Experimental inoculation of honey bees, mice, rats, and chicks all showed
evidence of a persistent infection (Bastian et al., 1984; Clark, 1964; Clark, 1969; Clark, 1974;
Kirchhoff et al., 1981; Tully et al., 1984)
Isolation: The Suckling Mouse Cataract Agent (SMCA) was originally isolated from a small
pool of rabbit ticks removed from a rabbit found dead on the road in Georgia in 1962.
Researchers were searching for rickettsiae in wild animals when they came across this organism.
SMCA was lethal to embryonated eggs but was nonculturable on a variety of bacterial or
mycoplasmal media. Due to its resistance to penicillin and streptomycin and its filterability
through a 220nm pore, it was assumed to be a virus (Clark, 1964). In 1973 it was described to
have mycoplasma-like characteristics when seen via electron microscopy (Zeigel and Clark,
1974).
Strain GT48 was also isolated from a pool of rabbit ticks collected in Georgia in 1962, hence its
name Georgia Tick 48 (Kotani et al., 1986). It was determined that GT48 was antigenically
indistinguishable from SMCA. This organism was also lethal to embryonated eggs, exhibited a
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similar host range in experimentally infected animals, and had similar morphology and
physicochemical characteristics as SMCA (Tully et al., 1984; Zeigel and Clark, 1974).
Media: SMCA and GT48 are usually cultured in SP4 medium; however, most laboratory strains
adapt well to M1D also (Regassa and Gasparich, 2006). Growth occurs from 25oC - 41oC with
the optimal temperature being 37oC. S. mirum does represent the more fastidious spiroplasmas
and, even at its optimal temperature, has a doubling time of 8 hours (Konai et al., 1996).
Due to its fastidious nature, attempts were made to cultivate S. mirum in a variety of mammalian,
avian and tick cell cultures but were unsuccessful due to cytopathic effects and slow growth from
the organism (Bastardo et al., 1974; Clark, 1964; Clark, 1974; Fabiyi et al., 1971; Yunker et al.,
1987). Chick embryo chorioallantoic membrane and yolk sac fragment cultures failed to support
growth (Clark, 1964). Successful cultures were made in a number of mosquito cell lines, and the
growth was equivalent to that seen in SP4 media with minimal cytopathic effects (Yunker et al.,
1987). Spiroplasma mirum was also able to grow in Drosophila Dm-1 cells, creating a chronic
infection when maintained at 25ºC but showed cytopathic effects at 30ºC (Steiner et al., 1982).
SMCA was also found to permanently transform NIH 3T3 mouse embryo fibroblast cells.
Transformed 3T3 cells exhibited loss of contact inhibition, aggregating into one foci on the
monolayer (Bove, 1997; Kotani et al., 1986). SMCA also transformed monkey kidney CV-1
cells (Kotani et al., 1986). Due to the formation of cataracts in suckling mice, Megraud et al.
experimented with ocular tissues and were able to establish spiroplasma growth on rabbit lens
cultures that were comparable to the growth seen in SP4 media (Megraud et al., 1983).
Disease/Pathology: Spiroplasma mirum is the only species found to be pathogenic to vertebrates
(Bove, 1997). As the name describes, SMCA, when inoculated intracerebrally, caused suckling
mice to develop cataracts (Clark, 1964). The organism was able to persist in suckling mice,
specifically the brain tissues, for up to two years (Clark and Karson, 1968). Due to this
observation, it was tentatively included in the slow viruses or chronic infectious neuropathic
agents (Hotchin, 1967). When inoculated into suckling rats, 70% developed cataracts and 36%
developed mild to severe hydrocephalus (Elizan et al., 1972). The organism causes death
between four and seven days post inoculation in seven day old embryonated eggs (Clark, 1964).
In one day old chicks inoculated intracerebrally or subcutaneously, the organism caused death
within five days (Clark, 1974). When inoculated intracerebrally into day old hamsters, CNS
signs and severe weight loss were observed (Kirchhoff et al., 1981). Death and severe
microphthalmia were seen in rabbits inoculated intracerebrally less than twenty-four hours after
birth. No clinical signs were seen when S. mirum was inoculated in adult mice, roosters,
hamsters, rabbits, guinea pigs, or rhesus monkeys (Clark, 1974).
Strain GT48 induces fatal encephalitis when inoculated intracerebrally into newborn mice and
rats (Clark, 1964). Suckling mice did not develop cataracts after inoculation with GT48 at even
low doses (Clark and Karson, 1968). Suckling rats developed cataracts as well as severe weight
loss after intraperitoneal or subcutaneous inoculation with GT48 (Bastian et al., 1987b). Strain
GT48 also causes death in seven day old embryonated eggs, although the deaths are more
sporadic and over a greater range of days (Clark, 1964). Table 1.3 summarizes clinical findings
found post S. mirum inoculation.
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Transmission: Spiroplasma mirum has only been isolated naturally from the rabbit tick. The
true pathogenicity has been questioned since the organism has only experimentally induced
disease either by inoculation into the yolk sac of seven day old chick embryos; intracerebral
injection into newborn rats, mice or hamsters; or by inoculation into the scarified cornea of adult
rabbits (Bove, 1997). The fastidious nature of the organism makes primary isolation challenging
and leaves researchers questioning other possible hosts.
Other information: Its persistence for long periods of time within the brains of experimentally
inoculated animals led researchers to presume that SMCA should be categorized as “slow virus.”
This family included the infectious agent for scrapie in sheep and the agent of Kuru in man
(Schwartz and Elizan, 1972). Tully suggested that this organism may be related to the causative
agent of scrapie which had not yet been identified (Tully et al., 1976). In 1979 Bastian reported
spiral membranous inclusions seen by electron microscopy in brain biopsy tissues from a patient
with Creutzfeldt-Jakob disease (CJD)(Bastian, 1979). Following this initial finding of
spiroplasma in CJD tissues, Reyes and Hoenig (Reyes and Hoenig, 1981) published two case
reports of patients that were suspected of CJD to have similar inclusions. Electron microscopy
revealed numerous membrane-bound vacuoles within the cell bodies of neurons and astrocytes.
Elongated, spiral, membranous inclusions were occasionally present within cortical cell
processes, as well as in synaptic terminals. Reyes also reported successful transmission of CJD
to spider monkeys from portions of brain tissues from one of these reported patients. In 1980
Gray reported a case of CJD to have spiral membranous inclusions, indicative of spiroplasma,
with five to eight twists seen via electron microscopy (Gray et al., 1980). In 1981 Bastian
reported two more cases of CJD with similar spiral-like inclusions seen through electron
microscopy (Bastian et al., 1981).
After these case findings, more research was committed to spiroplasma in association with CJD
cases. Since morphological evidence was all that suggested an association between spiroplasma
and CJD, other techniques, namely cultivation of the spiroplasma and serological tests, were
used to identify spiroplasmas from confirmed cases of CJD. These techniques failed to detect
the organism. No spiroplasma or other mollicutes were cultivated in SP4 medium from brain
tissue in eighteen cases, and no antibodies to several recognized Spiroplasma spp., including S.
mirum, were detected in sera from fifteen patients by immunofluorescence and metabolism
inhibition tests.(Leach et al., 1983)
In 1988 Humphery-Smith and Chastel proposed that the spiral-like inclusions seen in Gray and
Reyes’ cases were actually crystalline artifacts (Humphery-Smith and Chastel, 1988). Connolly
reported a number of unidentifiable structures in a CJD case via electron microscopy including
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Table 1.3 Summary of Spiroplasma mirum experimentally infected animals
Species

Age

Route

Death

Disease

Chicks

<24 h
<24 h
<96 h

IC
SQ
IC

4 days pi
5-6 days pi
Rarely

>5 days
<96 h
<96 h
Adult

IC
IP
IV
IC

No
No
No
No

Yellow livers and
swollen spleens
Cataracts 1
Stunting
Death
None
None
None
None

Rats

<96 h
<24 h

IV, IN, IP, cornea
IC
SQ/IP4

Yes
No

Deer Mouse
Roosters
Hamsters

Adult
Adult
<24 h

SQ
IM
IC

No
No
Variable

Rabbits

Adult
<24 h

IV
IC

No
12 days

Adult

IV, SQ
Scarified cornea
IP, IM, SQ, cornea
IP
IP
IV, SQ, cornea

No
No
No
No
No
No

Mice

Guinea Pigs
Box Turtle
Opossum
Rhesus Monkey

Adult
Adult
Adult
Adult

Cataracts 3
Cataracts
Weight loss
Alopecia
None
None
CNS signs
Dramatic loss of weight
Runting
None
Death
Severe microphthalmia
None
Ocular lesion
None
None
None
None

Persistence of
organism
NT
NT
827 days

Ref

133 days
9 days2
NT
497 days

(Clark and Karson, 1968)
(Clark and Karson, 1968)
(Clark and Karson, 1968)
(Clark and Karson, 1968)

NT
60 days
50 days

(Clark, 1974)
(Clark, 1974)
(Clark and Karson, 1968)

(Clark, 1974)
(Bastian et al., 1984)
(Bastian et al., 1987b)

NT
NT
NT

(Clark and Karson, 1968)
(Clark, 1974)
(Kirchhoff et al., 1981)

NT
12 days

(Clark, 1974)
(Kirchhoff et al., 1981)

NT
AB negative
NT
NT
NT
NT

(Kirchhoff et al., 1981)
(Clark, 1974)
(Clark, 1974)
(Clark and Karson, 1968)
(Clark and Karson, 1968)
(Clark, 1974)

IC: Intracereberal, SQ: Subcutaneous, IP: Intraperitoneal, IV: Intravenous, IN: Intranasal, IM: Intramuscular, NT: Not tested
1 Cataracts were the most common clinical manifestation of SMCA inoculation
2 Organism was not recovered from brain or eye tissues but was found in liver-spleen suspension
3 Cataracts in suckling rats were more severe with a higher inoculation levels
4 Rats were inoculated with GT48
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one which was tightly coiled, intranuclear, and which measured 570nm in length by 45
nm in width, but specified that no spiroplasma-like shapes were seen (Connolly et al.,
1988).
Further research was conducted to show similarities between the transmissible agent of
CJD and spiroplasma. Bastian reported that the tissue response to experimental
spiroplasma infection in the suckling rat brain resembles the spongiform degenerative
brain diseases of both man and other mammals. The degenerative changes are localized
to the gray matter, as seen in CJD cases (Bastian and Jennings, 1984). The optimal
growth temperature for S. mirum and other spiroplasma isolates was 37oC, suggesting
that spiroplasmas could be found in a mammalian host (Bastian and Jennings, 1984;
Konai et al., 1996). The organism’s proven ability to produce an acute or persistent brain
infection in small mammals was also used as evidence. Subsequent studies have shown
some resistance of spiroplasma organisms to chemical factors with some resemblance to
the resistance exhibited by the transmissible agent of CJD (Bastian and Fermin, 2005).
Bastian concluded that the size and membranous nature of spiroplasma organisms would
best fit with the data regarding the elusive CJD agent (Bastian et al., 1984).
In 1987 a scrapie-associated fibril was identified as a consistent finding and possible
infectious unit of the transmissible spongiform encephalopathies. Cross reactions with
this fibril to S. mirum fibril proteins supported evidence of an association between
spiroplasma and TSEs (Bastian et al., 1987a). In 2001 Bastian and Foster (Bastian and
Foster, 2001) reported the presence of spiroplasma ribosomal DNA in CJD and scrapieinfected brains. In 2004 eight of ten scrapie infected brains, five of seven CWD infected
brains, and two of two CJD brains were found to be positive for S. mirum via southern
blotting of PCR products (Bastian et al., 2004). PCR products obtained from the
scrapie, CWD, and CJD cases had 99% homology with published S. mirum 16S rDNA
sequences (Bastian et al., 2004). In this study, it was reported that the mode of DNA
extraction was critical. The most reliable method involved initial solubilization with
guanidine thiocyanate followed by phenol/chloroform extraction (Bastian et al., 2004).
Southern blotting was also acknowledged as the more sensitive method of detection,
allowing detection of spiroplasma DNA where PCR product was not readily apparent
(Bastian et al., 2004). This study is in contrast to the 2006 study of experimentallyinfected scrapie hamsters that found no evidence of bacterial 16S rRNA (Alexeeva et al.,
2006). It should be noted that Bastian’s tissues were all from naturally infected animals,
and those in Alexeeva’s study were experimentally infected.
In 2005 Bastian et al. (Bastian et al., 2005) isolated a spiroplasma from homogenates of
CWD and scrapie infected brains. The brains were homogenized in SP4 media and then
inoculated into eight day old embryonated eggs. Allantoic fluids from the inoculated
eggs were then passaged into SP4 media and incubated for sixteen days at 37ºC.
Evidence of spiroplasma growth was found via phase microscopy, electron microscopy,
and PCR. DNA sequence analysis showed 98% homology with S. mirum but revealed
nucleotide substitutions unlike any known spiroplasma strain. The isolates from this
experiment were later inoculated into neonatal goats and sheep (Bastian et al., 2007). No
clinical signs were seen, but all brains had evidence of spongiform changes. At eleven
months post inoculation, one goat and one sheep had severe cerebella and hippocampal
spongiform degeneration with neuronal vacuolization in the brain stem. All other
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animals were reported to have spongiform changes to a lesser degree. It was noted that
the intraneuronal vacuoles in the cerebellar cortex and brain stem seen in the Spiroplasma
spp. inoculated ruminants were identical to lesions typical of naturally occurring TSE
(Bastian et al., 2007).
In 2007 Bastian et al. induced spongiform encephalopathy in neonatal deer inoculated
intracerebrally with SMCA. Three of four deer developed clinical signs of neurological
deterioration between 1.5 months and 5.5 months post inoculation. One deer brain
showed signs of hydrocephalus, while all others were grossly normal. Histological
sections of all deer showed spongiform encephalopathy in the cerebral cortex, cerebellar
cortex, and the brain stem. Severity of neuropathology was noted as incubation time
increased. In the same publication, sheep were inoculated intracerebrally with varying
dilutions of SMCA. No clinical signs were noted, but spongiform encephalopathy was
seen histologically. Severity of lesions was decreased as the dosage of the inoculum
decreased. Neonatal goats were also inoculated intracerebrally with SMCA. After five
months no clinical signs were seen and only minimal vacuolization was noted
histologically (Bastian et al., 2007).
In another study, S. mirum failed to induce spongiform encephalopathy when
experimentally inoculated into 5.5 month old raccoons. Raccoons are used as an
experimental model for transmissible mink encephalopathy (TME). In this study, one
group of raccoons was inoculated intracerebrally with low doses of SMCA and another
group was inoculated intracerebrally with high doses of GT48. The strains of S. mirum
used in this study were adapted to growth at 31ºC with minimal passages in artificial
media. None of the raccoons had any clinical signs and no significant histological
changes could be found >900 days later (Hamir et al., 2011).
Most recently, a spiroplasma isolate has been recovered from ocular fluid taken
aseptically from scrapie-infected sheep. Minced corneal tissues were inoculated into
M1D, and spiroplasma organisms were evident via dark field microscopy. These
organisms did not propagate and the culture was lost after several passages (Bastian et al.,
2011). This has recently been repeated and efforts are ongoing to passage the spiroplasma
to a substantial culture (data not published).
Transmissible Spongiform Encephalopathies
Transmissible Spongiform Encephalopathies (TSEs) encompass a condition that affects
humans and a variety of animals with a fatal neurodegenerative disease and associated
neurological clinical signs. The disease presents with morphological and
pathophysiological features that parallel other progressive encephalopathies such as
Alzheimer’s and Parkinson’s diseases (Aguzzi and Haase, 2003). Research currently
supports evidence that the agent responsible for TSE is a prion, a small proteinaceous
infectious particle (Prusiner, 1982). The prion is a cell surface glycoprotein (Stahl et al.,
1987) with an unknown function. The pathogenesis for the prion is still widely unknown;
however it is accepted that the normal prion PrPC undergoes some sort of
posttranslational modification that converts it to a pathogenic prion PrPSC. PrPSC is an
insoluble and partially protease-resistant isoform that propagates itself by imposing its
abnormal conformation onto other PrPC molecules (Aguzzi and Calella, 2009). The
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human prion diseases include Kuru, CJD, variant CJD, Gerstmann-Straussler-Scheinker
(GSS) disease, and fatal familial insomnia (FFI). The most common animal TSEs are
scrapie, which affects sheep and goats; bovine spongiform encephalopathy (BSE); and
chronic wasting disease (CWD), which affects deer and elk.
Scrapie, the TSE disease of sheep and goats, was characterized as early as 1738 (Parry,
1983). The etiology of the disease can be traced back to a vaccination of sheep for
louping-ill virus with formalin-treated extracts of ovine lymphoid tissues that were
unknowingly contaminated with scrapie prions (Gordon, 1946). In 1998 atypical scrapie
was described in a herd of Norway sheep. Following this disease characterization, a
more active surveillance program was instituted in European countries and far more cases
of atypical scrapie were reported (A Buschmann, 2004; SJ Everest, 2006). Scrapie and
atypical scrapie can be easily transmitted through flocks, but the mechanism for disease
spread is still not understood (Aguzzi and Calella, 2009).
In 1986 an epidemic of BSE or “mad cow” disease occurred in Great Britain (Westaway
et al., 1987). The source of this disease spread was traced back to the meat and bone
meal nutritional supplements used in cattle feed (Wilesmith et al., 1992). The BSE
epidemic reached its peak in 1992 with over 35,000 cattle affected. Cases of BSE are
now rarely reported. Brain extracts of BSE cattle have transmitted disease to mice, cattle,
sheep, pigs, and non human primate marmoset after intracerebral inoculation (Baker et
al., 1993; Bruce, 1993; Dawson et al., 1990a; Dawson et al., 1990b; Fraser et al., 1988).
Chronic wasting disease (CWD), the TSE affecting deer and elk, was initially reported in
a captive research herd of deer in Colorado (Williams and Young, 1980). Cases of CWD
have since been detected in free-ranging mule deer (Odoncoileus hemionus), white-tailed
deer (O. virginanus), and Rocky Mountain elk (Cervus elaphus nelsoni) in areas close to
Colorado (Nebraska, New Mexico, and Utah) but also in distant states (Wisconsin,
Illinois, Canada) (Aguzzi and Calella, 2009). Research indicates that CWD is easily
transmitted among cervids through grazing in areas contaminated with prion-infected
secretions, excretions, tissues or decomposed carcasses (Miller and Williams, 2003;
Miller et al., 2004).
The human prion diseases have been classified as infectious, inherited, or sporadic,
depending on the clinical, genetic, and neuropathological findings. The clinical signs
include progressive dementia, myoclonus, visual or cerebellar impairment,
pyramidal/extrapyramidal signs, and akinetic mutism. With the exception of one case, all
reported CJD cases have been in people over 40 (Packer et al., 1980). The first
documented case of iatrogenic prion transmission occurred in 1974 from a corneal
transplantation from a CJD patient (Duffy et al., 1974). Iatrogenic transmission has also
been reported after neurosurgery with contaminated instruments (Bernoulli et al., 1977;
Davanipour et al., 1984; Masters and Richardson, 1978), human growth hormone (Brown
et al., 1985; Buchanan et al., 1991; Fradkin et al., 1991), and human pituitary
gonadotropin (Healy and Evans, 1993). Familial TSEs were characterized after discovery
of an autosomal dominant PRNP gene alteration, the gene encoding cellular PrP. The
three familial TSEs can be described clinically as fCJD: rapid progressive dementia with
myoclonus and pseudoperiodic discharges of electroencephalogram; GSS: slow
progression of ataxia followed by later onset dementia; FFI: refractory insomnia,
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hallucinations, dysautonomia, and motor signs. Sporadic CJD (sCJD) accounts for 85%
of all human prion diseases (Aguzzi and Calella, 2009). With sCJD there is no
association with mutant PRNP allele or any epidemiological evidence for TSE agent
exposure. New variant CJD (vCJD) was first described in 1996 and has been linked to
BSE (Will and Zeidler, 1996). New variant CJD is clinically characterized by psychiatric
abnormalities, sensory symptoms, and ataxia (Aguzzi and Calella, 2009). It is
distinguished by the abnormal age of onset (19y -39y) as opposed to sCJD (55y-70y) and
its shorter duration of illness.
Shortcomings to the Prion Theory
Opponents of the prion theory have argued that a protein alone cannot account for the
pathology caused in TSE diseases. Studies have shown that neuropathology and clinical
signs can be transmitted without the presence of the pathologic prion (Manuelidis and
Fritch, 1996; Sklaviadis et al., 1989). Manuelidis (Manuelidis and Fritch 1996)
experimentally infected thirty mice with BSE-infected cattle brain homogenates. All of
the mice exhibited clinical signs, but 55% of the mice had no detectable abnormal prion
PrPres accumulation. Brain homogenates from PrPres negative mice were inoculated into a
new set of mice which resulted in a mixture of PrPres negative and positive mice. After
the third passage of PrPres negative brain homogenates, all mice were PrPres positive. In
another prion study (Race et al., 2001), there was a one year period post-scrapie infection
where there was no evidence of replication of PrPres titers in mouse brains. Following
this period of inactivity a period of active replication of infectivity as well as adaptation
of new strains of agent capable of causing disease in mice was seen. In most mice,
neither the early phase nor the later replicative phase could be detected by immunoblot
assay for protease-resistant prion protein. The transmission of TSE without detectable
PrPres accumulation supports the theory that in addition to the abnormal prion an
infectious agent is likely.
With the development of a new cyclic amplification method for prions, the proteinmisfolding cyclic amplification (PMCA), more information has been learned about prions
in general. The PMCA is a method in which a subthreshold amount of any abnormal
strain of prion PrPTSE can, by repeated incubation and sonication in the presence of a
normal tissue homogenate, be increased to detectable levels (Castilla et al., 2005; Saa et
al., 2006a; Saa et al., 2006b). The sensitivity of the PMCA has contributed information
about the possible presence of misfolded protein species in normal brains. Experimental
studies on brain tissue from normal rodents (hamster, mice, and bank voles) subjected to
many rounds of PMCA cycling have yielded detectable amounts of PrPTSE and
infectivity. It has been suggested that misfolded PrP molecules are regularly produced in
normal brain tissue and require only one or more as yet unidentified triggers to unleash
the cascade of molecular events that terminate in symptomatic disease (Brown, 2008).
Manuelidis et al. suggests a virus is associated with the infectious agent of TSE
(Manuelidis, 1997). In one experiment, an attenuated strain of CJD was inoculated into
mice and provided interference in PrPres prion development and subsequent development
of clinical signs. Manuelidis also suggested that some populations could harbor an
attenuated CJD agent that makes them less susceptible to low-challenge doses of more
virulent CJD agents, citing the new variant CJD outbreak from BSE infected meat that
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only affected a few, although millions were exposed (Manuelidis, 1997). Researchers
have also reported that the inactivation, behavior and size of the scrapie agent are very
similar when compared to viral controls (Rowher, 1984). Studies of the scrapie agent’s
sedimentation behavior (Prusiner, 1978; Prusiner et al., 1980), exclusion size in
permeation chromatography (Diringer and Kimberlin, 1983; Kimberlin et al., 1971), and
buoyant density also suggest a virus (Diringer and Kimberlin, 1983; Kimberlin et al.,
1971). These studies are in contrast to previous research that showed the transmissible
agent to be more resistant to heat and fixatives than most viruses (Alper et al., 1966;
Burger and Gorham, 1977).
There is evidence that a normal prion isoform on the cell surface may be used as a
receptor for a bacterium (Watarai et al., 2003). This study suggests that the abnormally
folded prion is a product of the infection rather than the cause. The study was based on
the concept that intracellular bacteria use lipid rafts preferentially to enter the cell (Manes
et al., 2003). Entering the cell in this method, the bacteria are able to avoid degradation
pathways and lysosomes and both the adaptive and innate immune response (Manes et
al., 2003).
Further characterization of the pathogenic prion led to the discovery that this protein is
resistant to the potent protease potential of proteinase K (McKinley et al., 1983).
Resistance to proteinase K is one of the distinguishing characteristics of the prion. In
1987 Bastian et al. (Bastian et al., 1987a) showed that S. mirum also contained proteinase
K resistant proteins of 28, 30, 66, and 76 kDa. It was also suggested there is an
immunological cross-reactivity and morphological similarities to the scrapie prion. In
1991 evidence Butler (Butler et al., 1991) reported that many of the mollicutes contained
proteins that were also proteinase K resistant.
Other spiroplasmas are also implicated in neurological disease. Leafhoppers infected
with S. citri (Western-X disease) develop notable lesions in the optic lobes and salivary
glands (Nasu et al., 1970; Whitcomb et al., 1967). Simultaneous involvement of the optic
lobes and salivary glands in Western-X is similar to the occurrence of either Sjorgren’s
syndrome or mucosal inflammation with ocular manifestations in multiple sclerosis (MS)
(Coyle and Bulbank, 1989; Sandberg-Wollheim et al., 1992). Brown suggested that
infection of both plant phloem and insect axons indicates a predilection of the organism
for components of electrochemical conduction (Brown, 2003). There are also clinical
correlations with bee and wasp stings and the subsequent development of MS (Dionne et
al., 2000). These reports attribute the disease to bee venom; but bees and wasps are
known carriers of spiroplasmas, and Brown suggests that the inoculation of humans with
S. citri by bee or wasp stings could be the mechanism causing MS (Brown, 2003).
Humphery-Smith et al. (Humphery-Smith et al., 1992) suggested that S. melliferum is a
potential model for studying central nervous system degenerative disorders because of its
ability to multiply and survive for up to nine months in intracerebrally inoculated mice.
It was also found that this spiroplasma causes pathology in neuronal mitochondria in
vitro and in vivo. In 1992 a spiroplasma isolated from a tabanid also had the capability of
multiplication and survival in the suckling mouse brain (Humphery-Smith et al., 1992).
There is also clinical evidence that scrapie can be transmitted via hay mites in sheep. In
one experiment, mites from a known infected farm were collected, pooled and
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homogenized, and inoculated into mice. Prion disease developed 626 days later. In
subsequent passages the incubation time was reduced, and the author concluded that
mites could be a vector for the disease (Carp et al., 2000). Although mites are not one of
the major hosts for spiroplasma, Jaenike (Jaenike et al., 2007) showed that mites could
support different Spiroplasma spp. and therefore could act as a vector for transmission of
Spiroplasma spp. from host to host.
Discrepancies Seen in Spiroplasma mirum/TSE Publications
There have been many contradictory reports in the literature involving the culturing of S.
mirum, its resistance to disinfectants and antibiotics, and its role in TSE. This section
will be used to highlight those areas of interest. The contradictions will be the focus of
the research to follow.
In 1979 Bastian was the first to publish a spiral-like inclusion in CJD brains seen via
electron microscopy (Bastian, 1979). Gray and Reyes’ also reported similar findings and
published pictures (Figure 1.1 A) of the spiral inclusion (Gray et al., 1980; Reyes and
Hoenig, 1981). In 1988, Humphery-Smith reported that the inclusions seen in the Gray
and Reyes’ publication had very similar morphology to crystalline artifacts (Figure 1.1 B
and C)(Humphery-Smith and Chastel, 1988). In 1984 Bastian reported visualization of
the spiroplasma within vacuolated cells of GT48-inoculated brains. The morphology of
these organisms was drastically different from those identified in his CJD patients. These
findings were of filaments or crescent shapes, both which were also seen in a pelleted
sample of GT48 for comparison (Bastian et al., 1984).
Leach (Leach et al., 1983) followed up on the association of CJD and spiroplasma, based
solely on morphologic appearance via electron microscopy, with an attempt to isolate
spiroplasma from eighteen CJD patients. The brain tissues were homogenized in SP4 and
diluted. The dilutions were plated on SP4 plates, and the remaining cultures were
allowed to incubate for two weeks. Sera were also tested for spiroplasma by indirect
immunofluorescence and metabolism inhibition tests.

A
Figure 1.1 Spiroplasma-like inclusions
A) Spiroplasma-like inclusion seen in CJD brains by Gray B) Crystalline artifacts labele
and C) an example of Spiroplasma labeled all seen via electron microscopy.
The experimental design was possibly flawed in Leach’s experiments, in that incubation
was for two weeks only; and a culture was diluted, that if positive most likely had very
few organisms originally. The cultures were not reported to be passaged, and no other
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culture tissues (embryonated eggs) were used. Furthermore, no antibodies are found
circulating in experimentally infected animals (Clark, 1964), so the lack of inhibition
from the serum tested is not indicative of a non-infection. This is not to argue that
spiroplasma could be found in these CJD patients but to show the drawbacks in
experiments that question the S. mirum/TSE correlation.
In a 1984 publication, Bastian (Bastian et al., 1984) experimentally inoculated suckling
rats intracerebrally with GT48. He reported that at day 15, organisms were at a titer of
107 to 109; but those animals necropsied at day 60 had considerably lower titers. The
brains examined histologically at day 14 revealed microcystic encephalitis. The neuropil
was studded with vacuoles and showed a prominent inflammatory infiltrate of
polymorphonuclear leukocytes and mononuclear cells. Histological examination of brain
tissues obtained from rats at 25 days revealed minimal pathologic alteration. Bastian also
reported that organisms were readily identified via electron microscopy for rats sacrificed
at day 14 but not for rats sacrificed at day 25. In the 2005 publication, Bastian cited the
previous 1984 study as stating that infection with GT48 spiroplasma produces
perineuronal vacuoles, lack of inflammation and scattered microglia (Bastian and Fermin,
2005). The 1984 publication only found pathology with prominent inflammatory
infiltrates at day 14 and reported a lack of pathology by day 25 (Bastian et al., 1984).
Bastian also referenced this experiment again in the same publication stating in the rat
there is extensive spongiform degeneration without inflammatory response when in 1984
he reported prominent inflammatory infiltrates of white blood cells and pathology was
resolved by day 25 (Bastian and Fermin, 2005).
In 1984 another publication from Tully, Bastian and Rose reported on experimental
spiroplasma infections in rats (Tully et al., 1984). In this study, three different rat species
were inoculated intracerebrally with low or high doses of GT48. Histological sections
were not reported, only the persistence of the organism over 60 days for the three
different species. Responses were not uniform and the authors reported that some rats
receiving moderate to high levels of GT48 did not harbor viable organisms even in early
periods after challenge. They went on to suggest caution in assuming that S. mirum
strains always induce a consistent brain infection in the rat model (Tully et al., 1984).
In the 2005 publication listed above, Bastian also reports that Spiroplasma can resist
exposure to temperatures near boiling, as well as glutaraldehyde and other fixatives
(Bastian and Fermin, 2005). In 1964, Clark reported that SMCA was ether- and sodium
desoxycholate- sensitive and was efficiently inactivated by 0.5% phenol, 0.2% formalin,
and 0.05% B-propiolactone (Clark, 1964). Clark also found that SMCA was completely
inactivated following 30 minutes of heating at 56oC (Clark, 1964).
Although Bastian et al. was able to produce clinical and neuropathological signs with
SMCA-inoculated neonatal deer similar to those of CWD in his 2007 publication
(Bastian et al., 2007), attempts to reproduce this in other species has not been successful
(Hamir et al., 2011). Furthermore, evidence of recovery of the organism by culture,
antibodies, or PCR was not reported and allows further questions regarding spiroplasma
and its role in neurodegenerative diseases.
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The discrepancies listed above led to the interest in the association of spiroplasma and
TSEs and the development of the research proposed in this dissertation. Based on the
results reported by Bastian et al. in 2007, it is hypothesized that spiroplasma are
associated with neurodegenerative diseases similar to TSE. In this work we further
characterized S. mirum and continued to evaluate the possible correlations found in TSE
infections. In order to establish the best overall picture of S. mirum infections, we looked
at culture conditions, physical and environmental disinfectant resistance, pathology and
disease in experimental animals, and the immunological reactions found in experimental
animals. The following outlines the work in this dissertation.
In chapter two, we determined the optimal growth conditions for the laboratory strains of
S. mirum, SMCA and GT48. In M1D, both SMCA and GT48 grew better at 30ºC and a
typical growth curve was established. In embryonated egg cultures, SMCA caused death
in a reliable time frame and GT48 had sporadic death rates. Both results coincided with
previous research. Growth on solid media was established with SP4 plates, and colony
forming units were used to compare growth rates in liquid and solid media for both
strains of S. mirum.
Chapter three focuses on the resistance of spiroplasma to a variety of physical and
chemical disinfectants as well as antibiotics. Susceptibility was assessed by dilution and
time for common laboratory disinfectants and an antibiotic profile was established for
SMCA, GT48, S. citri, and S. melliferum. Information reported in this chapter was used
to compare the TSE infectious agent and spiroplasma.
Chapter four reports the clinical and pathological findings of our animal experiments. In
order to compare natural TSE infections to spiroplasma-induced disease, we established a
more long term animal model. It has been proven that the mouse model does not always
accurately portray a natural infection and so the ruminant model was chosen for disease
establishment. Neonatal goats were inoculated intracerebrally with SMCA and
monitored for clinical signs for two years. At the end of the experiment, various tissues
were collected and examined for pathology and persistence of the organism. Deer were
also inoculated at five months and monitored for clinical signs. Seven months postinoculation various tissues were collected and examined for pathology and persistence of
the organisms. Information from this experiment was compared to that of Bastian et al.
(Bastian et al., 2007) and their neonatal deer experiment. In order to test possible routes
of transmission SMCA was delivered by intravenous and intradermal routes in neonatal
goats to evaluate possible vector routes to establish an infection. Goats were monitored
for four months for clinical signs and persistence of the organism via various tissues.
After four months, various tissues were collected and examined for pathology.
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CHAPTER 2:
A COMPARISON OF CULTURE MEDIA FOR SPIROPLASMA SPP
Introduction
The successful recovery of mollicutes from clinical specimens is dependent upon a
number of factors, including host-dependent components (inhibitory enzymes, host
antibodies, etc) and a variety of cultural or technical factors that may either enhance or
limit isolation (Tully et al., 1983). It is established that no single culture medium or
cultivation procedure is adequate for the isolation of all or even most of the known
mollicutes (Tully et al., 1983). This is especially true for the unique and varied genus of
Spiroplasma. Spiroplasmas were classified as Mollicutes (then Mycoplasmas) in 1972
because they form “fried egg” colonies on solid media, pass through 0.22 μm filters, fail
to revert to walled bacteria, are completely resistant to penicillin, and lack cell wall or
murien cell wall precursors (Bove and Saillard, 1979; Saglio et al., 1971).
Spiroplasmas are a unique group of organisms. Originally thought to be viruses and then
mis-identified as spirochetes, spiroplasmas have been difficult to characterize. They can
be found in a variety of hosts including plants, insects, and ticks. They were first
recognized as helical, wall-less bacteria in 1972 and received their name from a
description of their motility in 1973 (Davis et al., 1972). The first named spiroplasma
was S. citri, the causative agent of citrus stubborn disease, which was originally
considered a virus (Saglio et al., 1971). Spiroplasma mirum, strain Suckling Mouse
Cataract Agent (SMCA), isolated from rabbit ticks, was first considered a virus because it
was filtered through such a small pore size (Clark, 1964). Spiroplasmas have also been
misidentified as spirochetes because of their similar appearance in dark field microscopy.
The sex ratio organism (SRO), a disease fatal to only males of certain Drosophila
species, was originally identified as a spirochete in 1961 but was later re-identified as a
spiroplasma (Williamson et al., 1983).
Spiroplasmas vary greatly in their habitats and therefore require a wide variety of culture
mediums for isolation and growth. Media designed for isolates from vertebrates stress
sodium concentrations and reduced potassium and supply nucleic acid precursors
(Whitcomb, 1983). Media designed for insect and flower isolates have much higher
concentrations of all amino acids. All spiroplasma media must contain a sterol or lipid
ingredient in order to support growth (Whitcomb, 1980). In general spiroplasma media
usually contain combinations of 10-20% serum, beef heart infusion, peptone and
tryptone, carbohydrates, and amino acids (Bove and Saillard, 1979; Chen and Davis,
1979; Whitcomb, 1980; Whitcomb, 1983). The first sustained cultivation of a
spiroplasma was S. citri, a flower pathogen, on a moderately simple mycoplasma medium
(see Table 2.1) (Whitcomb, 1983). The development of M1A resulted in enhanced
growth for insect/flower isolates. The addition of yeast extract for M1D media allowed
for better growth for some spiroplasma isolates. In order to cultivate SMCA, a fastidious
organism, a much more complex medium SP4 (see Table 2.1), with added nutrition,
especially amino acids, was required (Whitcomb, 1980). Isolates identified from
arthropods were thought to be non-cultivatable for years (Tully et al., 1982a). Clark
stated that one-half of the spiroplasmas observed in hemolymph of insects were non18

cultivatable with the media known in 1982 (Clark, 1982). Similar media are being used in
spiroplasma research today, making further isolation attempts challenging to researchers.

Table 2.1 Spiroplasma media (yields 300 mLs)
Ingredients
Standard Mycoplasma Medium M1A
M1D
SP4
Autoclave at 15 psi for 30 min
Mycoplasma broth
4.5 g
2.1 g
1g
base
Bacto-Tryptone
1g
3g
Bacto-Peptone
0.8 g
1.6 g
Glucose
0.1 g
Fructose
0.1 g
Sucrose
1g
Sorbitol
7g
Distilled water
200 mL
70 mL
197 mL
For solid media
Add 1.6 g Difco Noble Agar to
Add 2.4 g to 6.8 g Difco Noble
autoclavable portion
agar to autoclavable portion
Sterile filter
Schneiders Drosophilia
160 mL
medium
CMRL-1066 (10x
15 mL
w/glutamine, w/out
NaHCO3)
Fetal Bovine Serum
50 mL
50 mL
Horse Serum
60 mL
Fresh yeast extract
30 mL
10 mL 10.5 mL
(25%)
Phenol Red 0.5%
(0.1 %) 6mL
1.2 mL
1.2 mL
Potassium Penicillin
1.5 mL
2.5 mL
3 mL
(100,000 U/ml)
Yeastolate 2%
30 mL
Glucose (50% solution) 3 mL
3 mL
L-arginine-HCl 42%
1.5 mL

A defined media was also developed for S. mirum. After the growth experiments in SP4,
researchers began experimenting with a variety of different elements within the recipe in
order to determine the best recipe for S. mirum growth enhancement. H-1, a medium
containing sphingomyelin, was created (Hackett et al., 1987). This medium contains
lower concentrations of inorganic salts and higher concentrations of amino acids, nucleic
acid precursors, and cofactors. The addition of sphingomyelin and modifications made in
H-1 allowed SMCA’s doubling time to decrease from 25 hours to 7 hours with higher
growth yields (Hackett et al., 1987).
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Culture media has also been modified for different phases of the organisms’ growth.
Media used for isolation of the organism usually contain a rich mixture of nutrients.
However, some researchers suggest that for some isolates, the large amount of nutrients
could be toxic for isolation (Whitcomb, 1983). Primary isolation also depends on the
organism, hosts, and the number of organisms available for isolation (Friedlaender et al.,
1976). This was proven with repeated attempts to isolate spiroplasma from primary tick
material in different media (Tully et al., 1981; Yunker et al., 1987). In the case of S.
mirum isolation, it is speculated that an inoculum of low numbers may benefit from the
interaction with host cells. However, after four weeks of various tick cell line cultures,
all tissue cultures were not viable due to cytopathic effects on host cells and an artificial
media (SP4) was needed to sustain growth (Yunker et al., 1987). Once isolated, it is
common for the spiroplasmas to adapt to a simplified media for continued passage
(Whitcomb, 1983).
Spiroplasmas vary greatly in their ability to produce colonies on solid media. Although it
was one of the distinguishing characteristics in determining Spiroplasma is a mollicute
(mycoplasma), typical fried-egg or umbonate colony morphology is only observed under
poor growth conditions (Townsend et al., 1980; Whitcomb, 1983). Instead, some
spiroplasma produce small satellite colonies in the vicinity of primary colonies; others
produce granular-like colonies while still others form extremely diffuse colonies
(Whitcomb, 1980). The formation of colonies on solid media is dependent on a number
of factors, the greatest being the agar content. An effective strategy for obtaining
countable colonies with highly motile spiroplasmas is the incorporation of higher
concentrations of agar (Whitcomb, 1983). Interestingly, spiroplasmas have been found to
move faster with more viscous/more gelatinous media (Gilad et al., 2003; Wolgemuth
and Charon, 2005). The incubation conditions of the agar plates can also affect the
growth of spiroplasma colonies. Many isolates require a gaseous environment of 95% N2
and 5% CO2 for as long as 14-20 days (Bove and Saillard, 1979; Chen and Davis, 1979).
Variations in composition of solid media can also affect the ability of spiroplasmas to
form colonies (Whitcomb, 1980).
Qualitative and quantitative assessments of growth are required for spiroplasma cultures.
Qualitative monitoring of growth is important especially during continuous passage. If
media, temperature, pH, or osmolarity are not optimized, abnormal growth and
morphology may result (Chen and Davis, 1979; Liao and Chen, 1978). Phenol red has
been added as an indicator of growth based on acidic changes in the media because
cultures entering stationary phase reach a minimal pH (Whitcomb, 1980). SMCA, one of
the more fastidious organisms, is slow to acidify media and may reach stationary phase of
growth before acidifying the media. For this reason growth of cultures should be
confirmed by dark field or phase microscopy (Whitcomb, 1980).
Direct quantification of spiroplasmas is accomplished by counting helical organisms
under dark field microscopy (Liao and Chen, 1977; Williamson, 1969). This can be time
consuming and requires the use of a dark field microscope. Colony-forming units
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(CFUs) can be obtained by plating liquid culture and counting colonies 7-10 days after
incubation (Bove and Saillard, 1979; Whitcomb, 1980). Accurate counts of CFUs may
be difficult to obtain with spiroplasmas. Viable organisms from older cultures are less
likely to form colonies than those in log phase (Whitcomb, 1980). As stated above,
spiroplasmas vary in their ability to produce consistent colonies on solid media for
various reasons. Some researchers have found that using titration methods resulted in
accurate counts of spiroplasma cultures. In a dilution series, the highest dilution that
shows spiroplasma growth as exhibited via a color change is considered to contain one
color changing unit (CCU) (Whitcomb, 1980). This is a statistically crude estimate of
viable spiroplasma cells but has worked well for estimating organism numbers for the
more fastidious organisms (Whitcomb, 1980).
Indirect quantification methods have been developed for some spiroplasmas. Absorbance
at 660 nm may be used to measure growth of S. citri (Whitcomb, 1980); however the
measurements of absorbance or turbidity in most spiroplasma cultures may be affected by
nonspecific changes in the growth media, some which are not necessarily growth related
(Whitcomb, 1980). Incorporation of radioactive precursors into nucleic acids has also
been used to indirectly quantify S. citri (Bove and Saillard, 1979). This method measures
the radioactivity of trichloracteic acid insoluble precipitates during logarithmic growth.
ATP, total adenylate pools, and amounts of incorporated radioactive thymidine and
phenylalanine also increase during the logarithmic growth phase (Saglio et al., 1971;
Saglio and Whitcomb, 1979). Thymidine uptake as a measurement of growth was
evaluated for S. mirum, one of the more fastidious spiroplasmas. The growth yields were
not as high as the compared CFU counts of the same inoculum, but the same growth
curve pattern was seen in both media (Bastian et al., 1988).
Spiroplasma growth depends on temperature, medium composition, history of inoculum,
and history of passage in other mediums (Chen and Davis, 1979; Davis, 1978; Liao and
Chen, 1978). Growth rates appear to correspond closely with the organism’s natural
environment (Junca et al., 1980). Those spiroplasma found on flower surfaces have rapid
growth rates with doubling times of about 1.8 hr (Whitcomb, 1980). Spiroplasma citri,
which can be found in insects and within plants, grows less rapidly with a doubling time
of 5-6 hr (Saglio and Whitcomb, 1979). Those spiroplasma that have specialized habitats
grow slowly with doubling times of 20 hr or more (Liao and Chen, 1977).
The focus of this chapter is to establish optimal culture methods for laboratory strains of
S. mirum. A stock solution of SMCA and GT48 are used in all experiments. Stocks of S.
melliferum (ATCC strain BC-3 #33219) and S. citri (ATCC strain R8A2 #27556) were
also used in broth experiments for growth comparisons. In this laboratory, SMCA and
GT48 were better adapted to M1D broth media than SP4 for continued passages for
experimental purposes. To optimize the best culture method for laboratory strains,
spiroplasma growth studies in M1D broth, SP4 solid media, and embryonated eggs were
compared. Direct quantification was assessed via dark field microscopy in broth cultures
and embryonated egg cultures. Colony forming units were used for quantification from
SP4 plates.
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Materials and Methods
Bacteria: Two strains of S. mirum were used, SMCA and GT48. Strain SMCA was
obtained from Dr. Frank Bastian, Tulane Medical Center, New Orleans, LA. GT48,
ATCC strain #29334, was obtained from ATCC Bioresource Center. Spiroplasma
melliferrum (ATCC strain BC-3 #33219 Vc161, created on 17MAR90, pass # 3) and S.
citri (ATCC strain R8A2 #27556 130 Allen, created on 15Mar95, pass # 4) were also
obtained from the ATCC Bioresource Center.
M1D Media: The ingredients for M1D are seen in Table 2.1. Media was filter sterilized
through a 0.2 µm filter and stored at -4oC. Media was heated to room temperature and
containers were sterilized with 70% ethanol before use to reduce possible bacterial
contamination. Once inoculated with bacteria, media was monitored for growth via dark
field microscopy and/or color change.
Embryonated Eggs: Pathogen-free eggs were obtained from the Poultry Science Unit at
Louisiana State University Agricultural Center. Prior to use, eggs were stored at 18°C
and then incubated for 7 days in a humidified 37°C chamber. After 7 days, eggs were
candled for viability (Figure 2.1). Viable eggs were cleaned with 70% ethanol or 10%
betadine, and a sharp metal pick was used to make a small hole at the crown of the egg
above the air sac (Figure 2.2).

Figure 2.1 Egg Candling

Figure 2.2 Egg inoculation

A 10 μl sample was injected via a 22 gauge 1 inch needle into the allantoic cavity by
inserting the needle 3/4th of the way into the egg. Samples were injected into the yolk sac
by inserting a 22 gauge 1 inch needle at a 90° angle 3/4th of the way into the egg. The
injection opening was closed using candle wax or finger nail polish. Figure 2.3 details
the placement of each injection route. The blue line represents the path of chorioallantoic
inoculation; the red line, the path of yolk sac inoculation.
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Figure 2.3 Egg inoculation routes

Figure 2.4 Allantoic fluid collection

After injection, eggs were placed in a humidifying 37°C incubator (rocking or nonrocking) and candled daily for viability. On day 18 (11 days post inoculation) or when
determined to be non-viable, eggs were cooled to -4°C. Eggs were cleaned again with
70% ethanol. Approximately 1 mL of allantoic fluid was aspirated from each egg using a
22 gauge needle placed at a 45º angle through the sealed hole used for injection (Figure
2.4). Collected allantoic fluid was observed via dark field microscopy. Fluid was either
frozen at -80°C or passaged into new embryonated eggs or M1D.
SP4 Plates: A modified SP4 recipe was used for the plates in these experiments.
Ingredients for plates can be found in Table 2.2. The base solution was autoclaved for 30
min at 121°C, 15 psi and then cooled to 56°C. Supplements were combined and filter
sterilized through a 0.2 µm filter and then heated to 56°C. Once combined, media was
poured immediately into plates which were left under a hood until dry. Recipe makes
approximately 18 100 x 15 mm plates. Plates were incubated overnight at 37° to check
for bacterial contaminates.

Table 2.2 ATCC SP4 recipe
Base Solution
Mycoplasma Broth Base
Tryptone
Distilled H2O
Noble Agar
Supplements
Fetal Bovine Serum
Glucose (5%)
Phenol Red (0.1%)
Yeastolate (2%)
CMRL 1066 (10X)
Fresh Yeast Extract (25%)
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5.5 g
5g
262.5 mL
4g
85 mL
50 mL
10 mL
45 mL
25 mL
17.5 mL

Dark Field Microscopy: A 5 µL culture sample was placed on a clean glass microscope
slide, mounted with a #1.5 cover slip and sealed on all 4 sides with clear finger nail
polish. Slides were examined with a Ziess Axio Imager A1 microscope (Carl Zeiss, Inc.
North America, Thornwood, NY, USA) equipped with a dark-field top lens condenser
1.2-1.4 and an EC Paln-NeoFluar x100 oil immersion objective (Carl Zeiss, Inc. North
America, Thornwood, NY, USA) with 1.3 iris closed to its lowest setting (0.7).
Dark Field Enumeration: The average of at least 3 separate counts taken from various
areas of the 5 μl sample was multiplied by the area of the viewing space. This yielded the
approximate number of organisms per 5 μl samples. Cultures were assumed to be
uniform, and calculations were made to establish amount of spiral organisms per mL.
The grid size used to enumerate samples was determined and a formula (484 x 100 x the
average of three counts) was used to calculate the amount of organisms per 5 µL. This
number was used to calculate the total number of organisms per mL and reported in
Tables 2.4 – 2.11. Organisms per mL were log 10 trasformed for graphing purposes and
reported in Figures 2.6 – 2.8.
PCR Methods: PCR was carried out using oligonucleotide primers that specifically
identified a 1460 bp portion of the S. mirum-related adhesin gene. The forward and
reverse primers were F3 (5’-TCTAGTCTTAATCATTTTACTTATTTATTAGAA -3’)
and R4 (5’-TTATTAAGTCATTCACTCTCTTTCTTT -3’) respectively.
The reaction mixture (50 µL total) contained 2 µL of each the forward and reverse
primers (10 µM each), 1 unit (0.2 µL) of Taq DNA Polymerase (New England BioLabs,
Ipswich, MA), 2 µL of 10 mM dNTP (AmpliTaq Gold, Applied Biosystems, Foster City,
CA), and 5 µL of 10x Standard Taq Buffer (New England BioLabs), which contains 15
mM of MgCl2. For M1D cultures, 2 μL of culture was added to the reaction mixture
without prior DNA extraction. For SP4 plates, agar plugs were taken from 0.8% plates
and mixed with PBS. 2 μL of this solution was added to the reaction mixture. Plates
with higher concentrations allowed cotton swabbing of the surface. The cotton swab was
vigorously mixed in PBS and 2 μL of this solution was added to the reaction mixture. A
variety of allantoic fluid dilutions were used for PCR from embryonated eggs. Each
reaction was brought to a final volume of 50 μL with sterile, nuclease-free H2O. PCR’s
were performed using a MyCycler Thermal Cycler (Bio-rad). The thermal cycler
program used was 94ºC for 5 minutes, then 30 cycles at 94ºC for 30 seconds, 57ºC for 20
seconds, and 72ºC for 120 seconds followed by a final extension of 72ºC for 10 minutes.
All PCR products were electrophoresed on a 1% agarose gel in Tris-acetate-EDTA
(TAE) buffer, and the DNA was visualized by SYBR Safe (Invitrogen, Eugene, OR)
DNA gel staining under UV fluorescence.
Statistical Analysis: To determine the best growth conditions we used an analysis of
variance of a factorial arrangement of treatments was conducted. Treatment groups
included time, temperature, organisms, and daily growth counts. When overall
differences were found post-hoc comparisons were conducted with Tukey’s HSD test for
main effects and pairwise t-test for interaction effects. All comparisons were considered
significant when p 0.05.
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Experiment 1. Growth in M1D
1a. Growth at 30°C vs. 37°C: To assess optimal growth temperature, all three
species of Spiroplasma were incubated at 30°C and 37°C temperatures. Cultures
were initiated by adding 100 µL of thawed bacteria stock cultures to 900 μL of M1D
in a 3 mL polystyrene tube. Tubes were placed in a 30°C or 37°C incubator and
checked daily for color change. A 5 μL sample of each culture was assessed via dark
field microscopy daily for 7 days and then once weekly for a total of 21 days.
1b. Growth patterns of diluted cultures: Tenfold dilutions out to 10-8 were made from
a fresh 7 day old culture for both SMCA and GT48 strains and were incubated as
above. Growth was monitored daily via dark field microscopy, color change, and
PCR for 21 days.
1c. Medusa formation: While monitoring cultures daily for growth, it was observed
that SMCA and GT48 aggregated to form medusa-like structures which could affect
accurate counts. In order to test this, a fresh culture was made by 1:100 dilution of a
21 day culture and monitored. When five or more medusas were noted within the
daily sample taken for dark field microscopy, the culture was vortexed for a varied
amount of time: 1 minute, 5 minutes, and 10 minutes. Culture was checked after
vortexing for the presence of medusa-like aggregates by dark field microscopy. The
culture was monitored for growth daily for 7 days and compared to a culture not
vortexed.
Experiment 2. Growth in Embryonated Eggs
2a. Injection site and incubation: To optimize the culture method in embryonated
eggs, both injection site and type of incubator was assessed. 36 pathogen-free eggs
were incubated at 37°C in a rocking humidifying incubator for 7 days. A 10 μL
sample of 7 day old SMCA cultures was injected into 24 eggs via either the yolk (12)
or allantoic cavity (12) of the eggs. A 10 μLsample of M1D was injected into 12
eggs via either the yolk (6) or allantoic cavity (6) of the control eggs. Six eggs from
each injection route and controls were placed in a 37°C non-rocking humidifying
incubator. The remaining eggs were returned to the rocking incubator. Eggs were
candled daily to check viability. On day 18 (11 days post inoculation) or at time of
non viability, eggs were cooled to -4°C. Allantoic fluid was collected and observed
via dark field microscopy. Egg deaths and dark field results were recorded per day.
Egg deaths that occurred 1 day post inoculation were attributed to technical problems
rather than bacterial deaths.
2b. Comparison of egg deaths for GT48 and SMCA: Tenfold dilutions out to 10-8
were made from fresh 7 day old cultures for both SMCA and GT48 strains. Ninety
eggs were divided into groups of 6 and incubated at 37°C in a rocking humidifying
incubator for 7 days. A 10 μL sample of each dilution (7 dilutions of each strain:
SMCA and GT48) was injected into 7 day old embryonated eggs. A 10 μL sample of
M1D was injected into 6, 7 day old embryonated eggs to serve as controls. All eggs
were placed in a 37°C non-rocking humidifying incubator. Eggs were candled daily
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to check viability. On day 18 (11 days post inoculation) or at time of death eggs were
cooled to -4°C. Allantoic fluid was collected and observed for presence of organisms
via dark field microscopy and PCR. Experiment was repeated for accuracy of results.
Egg deaths and dark field results were recorded per day. Egg deaths that occurred 1
day post-inoculation were attributed to technical problems rather than bacterial
deaths.
2c. SMCA effects on embryonated eggs: The development of the chick causes a
great deal of changes within the embryonated egg. In order to assess the effects
SMCA has on the development of embryonated eggs, 20 eggs were monitored daily
for pH changes. Twelve eggs were injected with 10 μL of viable SMCA culture. To
serve as controls, 3 eggs were injected with 10 μL of M1D and 3 eggs were not
inoculated. At time of inoculation a small aspirate of allantoic fluid was taken and
pH was assessed with a 6-10 pH strip. All eggs were placed in a 37°C non-rocking
humidifying incubator. Eggs were candled daily to check viability. A sample of
allantoic fluid was taken daily from all viable eggs for 7 days and tested on pH strip.
All samples were also assessed for presence of bacteria via dark field microscopy.
Experiment 3. Growth on SP4 Plates
3a. Bacteria growth characteristics: Four 1 mL aliquots of 7 day old cultures (SMCA,
GT48, S. citri, and S. melliferum) were spun down at 16000xg for 1 hour. The pellet
was re-suspended in varying amounts of PBS, and each was inoculated onto modified
SP4 plates containing 4 grams of noble agar (Table 2.2). Plates were incubated at
30°C and 37°C for 14 days, and colonies were observed and counted when possible.
3b. Agar concentration experiments: Plates were made following the ATCC SP4
recipe with 4 grams (0.8%), 8 grams (1.6%), and 12 grams (2.4%) of Noble agar.
Tenfold dilutions of SMCA and GT48 were made in M1D, and 50 μL of each dilution
was placed on the agar plates. Plates were allowed to incubate for 14 days at 30°C
and 37°C, and colonies were observed and counted.
Results
Experiment 1. Growth in M1D
1a. Growth at 30°C vs. 37°C : Incubation at 30°C proved to be significantly better
(p 0.05) for all four species of spiroplasma based on daily dark field enumeration.
Spiroplasma citri had limited growth at 37°C. Spiroplasma melliferum cultures were
sustained at both temperatures, with 30°C yielding higher numbers. SMCA and
GT48 had very similar growth patterns at 30°C and 37°C, with 30°C sustaining
cultures for longer time period. Figure 2.6 and Table 2.3 highlights the dark field
counts obtained at various time points.
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Figure 2.5 Spiroplasma organisms as seen via dark field microscopy.

30ºC
37ºC

Age of culture

Figure 2.6 Comparisons of Spiroplasma growth yields over 3 weeks at 30°C and 37°C.
Growth yields were determined by dark field observations and compared by pairwise ttest of least squares means for significance where p 0.05. Spiroplasma citri, S.
melliferum, GT48, and SMCA had significantly better growth at 30°C.
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Table 2.3 Summary of Spiroplasma growth. Dark field counts at various time points
throughout the experiment for all three Spiroplasma species at each temperature tested.
*: No organisms found via dark field microscopy.
Organisms/mL
Organism
Temp
Day 1
Day 3
Day 5
Day 7
Day 14 Day 21
30°C
3.7E+07 2.8E+08 3.1E+08 2.6E+08 2.6E+08 7.7E+07
SMCA
37°C
1.5E+08 2.4E+08 2.6E+08 1.2E+08 5.1E+07 1.3E+07
SMCA
30°C
2.1E+07 1.7E+08 3.2E+08 2.7E+08 3.2E+08 1.5E+08
GT48
37°C
1.4E+08 2.9E+08 2.4E+08 2.4E+08 2.8E+07 2.8E+07
GT48
S. melliferum 30°C 2.7E+08 3.6E+08 1.8E+08 2.6E+08 1.8E+08 9.0E+07
S. melliferum 37°C 3.3E+08 1.8E+08 4.6E+07 2.5E+08 6.8E+07 1.2E+08
30°C
3.1E+07 1.8E+08 2.1E+08 1.6E+08 1.4E+08 3.7E+07
S. citri
37°C
1.8E+07 7.5E+06 3.2E+06 2.2E+06
*
*
S. citri
1b. Growth patterns of diluted cultures: Growth for all dilutions of GT48 and SMCA
at 30°C and 37°C can be seen in the following figures (Figure 2.8 and 2.9) and tables
(Tables 2.4 – 2.11). For GT48 and SMCA cultures between 1-7 days, growth at 37°C
was significantly better (time points highlighted with * when p 0.05) or the same as
growth at 30°C. However, after day 7, growth at 30°C was significantly better (time
points highlighted with * when p 0.05).
Cultures were also monitored via PCR. The PCR results from 3 days post-inoculation
are seen in Figure 2.7. As seen via dark field, more organisms were seen in diluted
cultures earlier in the 37°C cultures. Figure 2.10 reveals PCR results for 8 days postinoculation. SMCA has reached higher numbers at 30°C as seen with banding in the
lower dilutions compared to the bands for 37°C. Positive bands are seen at 1460 bp,
correlating with the S. mirum-related adhesin gene.

M M

1 2 3 4 5 6 7 8 9 10 1 2 3 4 5 6 7 8 9 10

Figure 2.7PCR results for tenfold dilutions of SMCA at 30°C and 37°C three days postinoculation. The first two lanes are markers. The next ten lines represent tenfold
dilutions of SMCA cultures at 30°C, followed by tenfold dilutions of SMCA at 37°C.
Positive bands are seen at 1460 bp, correlating with the S. mirum-related adhesin gene.
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Figure 2.8 Growth of diluted (1x10-2 - 1x10-5) GT48 and SMCA cultures over 3 weeks at 30°C and 37°C. Growth yields were determined by
dark field observations and log transformed data was compared by pairwise t-test of least squares means for significance where p 0.05 (time
points designated with * when p 0.05).
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Table 2.4 Dark field counts for diluted (1x10-2) SMCA and GT48 cultures
Organism Temp
Dark field counts: organisms/mL
Day 1
Day 3
Day 5
Day 7
Day 14
SMCA
30°C 2.1E+07 1.7E+08 3.2E+08 2.7E+08 3.2E+08
SMCA
37°C 1.4E+08 2.9E+08 2.4E+08 2.4E+08 2.8E+07
GT48
30°C 3.7E+07 2.8E+08 3.1E+08 2.6E+08 2.6E+08
GT48
37°C 1.5E+08 2.4E+08 2.6E+08 1.2E+08 5.1E+07

Day 21
1.5E+08
2.8E+07
7.7E+07
1.3E+07

Table 2.5 Dark field counts for diluted (1x10-3) SMCA and GT48 cultures
Organism Temp
Dark field counts: organisms/mL
Day 1
Day 3
Day 5
Day 7
Day 14
SMCA
30°C 5.7E+06 2.2E+08 2.5E+08 1.9E+08 2.5E+08
SMCA
37°C 9.4E+07 1.6E+08 2.0E+08 2.0E+08 3.7E+07
GT48
30°C 7.1E+06 1.2E+08 1.1E+08 2.3E+08 2.8E+08
GT48
37°C 4.1E+07 1.2E+08 2.6E+08 1.2E+08 3.9E+07

Day 21
2.2E+08
2.1E+07
1.6E+08
1.5E+07

Table 2.6 Dark field counts for diluted (1x10-4) SMCA and GT48 cultures
*: No organisms seen via dark field microscopy
Organism Temp
Dark field counts: organisms/mL
Day 1
Day 3
Day 5
Day 7
Day 14
SMCA
30°C 1.1E+06 7.3E+07 9.4E+07 4.3E+08 2.5E+08
SMCA
37°C 3.9E+07 1.7E+08 2.5E+08 1.9E+08 9.6E+07
GT48
30°C
*
3.6E+07 1.1E+08 2.7E+08 5.0E+08
GT48
37°C
*
7.4E+07 1.4E+08 1.9E+08 6.7E+07

Day 21
3.3E+08
1.3E+07
2.3E+08
2.6E+07

Table 2.7 Dark field counts for diluted (1x10-5) SMCA and GT48 cultures
*: No organisms seen via dark field microscopy
Organism Temp
Dark field counts: organisms/mL
Day 1
Day 3
Day 5
Day 7
Day 14
SMCA
30°C
*
2.1E+07 4.4E+07 2.6E+08 3.8E+08
SMCA
37°C 5.8E+06 8.5E+07 2.1E+08 1.7E+08 3.0E+07
GT48
30°C
*
3.2E+06 5.8E+07 1.7E+08 4.0E+08
GT48
37°C
*
2.8E+07 8.8E+07 2.6E+08 4.1E+07

Day 21
2.3E+08
1.4E+07
1.5E+08
1.7E+07
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Figure 2.9 Growth of diluted (1x10-6 - 1x10-9) GT48 and SMCA cultures over 3 weeks at 30°C and 37°C. Growth yields were determined by
dark field observations and log transformed data was compared by pairwise t-test of least squares means for significance where p 0.05 (time
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points designated with * when p 0.05).
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Table 2.8 Dark field counts for diluted (1x10-6) SMCA and GT48 cultures
*: No organisms seen via dark field microscopy
Organism Temp
Dark field counts: organisms/mL
Day 1 Day 3
Day 5
Day 7
Day 14 Day 21
SMCA
30°C
*
* 6.0E+07 1.5E+08 1.7E+08 2.2E+08
SMCA
37°C
* 3.0E+07 1.8E+08 1.9E+08 9.5E+07 2.6E+07
GT48
30°C
*
* 1.0E+07 1.3E+08 3.5E+08 1.5E+08
GT48
37°C
* 5.8E+06 1.1E+08 1.8E+08 1.4E+08 2.1E+07

Table 2.9 Dark field counts for diluted (1x10-7) SMCA and GT48 cultures
*: No organisms seen via dark field microscopy
Organism Temp
Dark field counts: organisms/mL
Day 1 Day 3 Day 5
Day 7
Day 14
Day 21
SMCA
30°C
*
* 1.1E+07 4.8E+07 2.1E+08 1.5E+08
SMCA
37°C
*
* 1.9E+08 2.1E+08 1.0E+08 1.6E+07
GT48
30°C
*
*
* 6.3E+07 4.7E+08 1.5E+08
GT48
37°C
*
* 5.4E+07 1.4E+08 1.2E+08 1.9E+07

Table 2.10 Dark field counts for diluted (1x10-8) SMCA and GT48 cultures
*: No organisms seen via dark field microscopy
Organism Temp
Dark field counts: organisms/mL
Day 1 Day 3 Day 5
Day 7
Day 14
Day 21
SMCA
30°C
*
*
* 1.4E+07 2.9E+08 7.7E+07
SMCA
37°C
*
* 1.8E+07 1.6E+08 5.2E+07 1.4E+07
GT48
30°C
*
*
* 9.0E+06
*
*
GT48
37°C
*
* 2.8E+07 1.4E+08 1.1E+07 1.1E+07

Table 2.11 Dark field counts for diluted (1x10-9) SMCA and GT48 cultures
*: No organisms seen via dark field microscopy
Organism Temp
Dark field counts: organisms/mL
Day 1 Day 3 Day 5
Day 7
Day 14
Day 21
SMCA
30°C
*
*
* 3.6E+06 2.3E+08 1.5E+08
SMCA
37°C
*
*
* 7.9E+07 1.9E+07 5.8E+06
GT48
30°C
*
*
*
*
*
*
GT48
37°C
*
*
* 4.4E+07 1.4E+07 9.7E+06
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Figure 2.10 PCR results for tenfold dilutions of SMCA at 30°C and 37°C eight days postinoculation. The first two lanes are markers. The next ten lines represent tenfold dilutions of
SMCA cultures at 30°C, followed by tenfold dilutions of SMCA at 37°C. Positive bands are seen
at 1460 bp, correlating with the S. mirum-related adhesin gene.
1c. Medusa formation: After 1 minute of vortexing, large medusas were still present when
examined with dark field microscopy. After 5 minutes, only small to medium medusas
(Figure 2.11) were still present. After 10 minutes, no medusas were present. The vortexed
culture was monitored for growth daily for 7 days and compared to a non-vortexed control
culture. The growth curve for vortexed and non-vortexed cultures had no significant
differences.

Figure 2.11 An example of a medusa or aggregate of spiroplasma organisms
Experiment 2. Growth in Embryonated Eggs
2a. Injection site and incubation: 100% (6/6) of yolk-injected embryonated eggs and 33%
(2/6) of allantoic-inoculated eggs that were placed in a non-rocking incubator died within 4-8
days post inoculation. Only 33% (2/6 ) yolk-injected eggs and 16% (1/6) of allantoicinoculated eggs died after continuing to incubate in a rocking incubator for 11 days post
inoculation. There were no deaths in control eggs with either treatment. Figure 2.12 depicts
the results from this experiment.
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Figure 2.12 Comparison of egg viability when injected via allantoic or yolk sac inoculations and
incubated in a rocking or non-rocking incubator.
2b. Comparison of egg deaths for GT48 and SMCA: SMCA had a lethality rate of over 70%
for all 7 dilutions. GT48 inoculation resulted in fewer egg deaths as the culture was diluted.
Visual evidence of spiroplasma in the allantoic fluid via dark field microscopy from non
viable eggs was higher for GT48 deaths than for SMCA deaths. Figures 2.13 and 2.14 depict
the percentages for deaths and those with positive dark field microscopy.

10-2

10-3

10-4

10-5

10-6

10-7

10-8

Figure 2.13 Comparison of pathogenicity of SMCA and GT48 in embryonated eggs. Results are
shown from tenfold dilutions of SMCA and GT48 cultures inoculated into embryonated eggs via
the yolk sac inoculation route and incubated in a non-rocking incubator.
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Figure 2.14 Comparison of observed Spiroplasma organisms from non-viable embryonated
eggs.
2c. SMCA effects on embryonated eggs: Figure 2.15 depicts the difference in daily readings
of pH in SMCA infected eggs and control eggs. Results from M1D and non inoculated eggs
are included for the control pH. The average of all eggs within each group was calculated for
these results. If egg death occurred, a note was made and calculations were adjusted based
on viable eggs at day of reading. Embryonated eggs inoculated with SMCA resulted in a
lower pH than the control eggs. The difference in pH was not found to be significant.

Figure 2.15 Comparison of pH readings in control embryonated eggs and Spiroplasma
inoculated embryonated eggs.
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Experiment 3. Growth on SP4 Plates
3a. Bacteria growth characteristics: SP4 plates made with 4 grams (0.8%) of Noble agar
revealed diffuse colonies for both SMCA and GT48. S. melliferum and S. citri SP4 plates
had evidence of multiple small pinpoint colonies throughout the plate. SMCA and GT48
inoculated plates revealed circular bodies with multiple satellite bodies when examined under
light microscopy which could be found at multiple levels within the agar. Results revealed
that dilution would be necessary to allow for individual colony growth, and better growth
may be observed on a more solid media. An example of GT48 and S. melliferum growth can
be seen in Figure 2.16. Figure 2.16 A shows 4 inoculation sites of 20 µL GT48 culture (not
diluted). Figure 2.16 B shows a view of colonies at 10x under light microscopy. Figure 2.16
C shows the growth of 50 μL of non-diluted S. melliferum culture placed in the center of the
plate and allowed to incubate for 10 days at 30°C.

A

B

C

Figure 2.16 GT48 and S. melliferum growth on 0.8% Noble agar SP4 plates. Plates were
incubated at 30°C for 10 days. A) 4 inoculation sites of 20 µL GT48 culture (not diluted). B)
view of colonies at 10x under light microscopy. C) Growth of 50 μL of non diluted S.
melliferum culture placed in the center of the plate and allowed to incubate for 10 days at 30°C.
3b. Agar concentration experiments: Results for 0.8% agar plates are seen in Figure 2.16.
SP4 plates made with 1.6% of noble agar revealed small somewhat irregular colonies for
both SMCA and GT48 (Figure 2.17). All colonies appeared to be on or near the surface of
the agar. Counts were made and recorded in Table 2.12. Based on pairwise t-test, colony
forming units were significantly (p 0.05) higher at 37°C than 30°C for both GT48 and
SMCA on 1.6% agar SP4 plates. SP4 plates made with 2.4% agar revealed “fried egg”
colonies for SMCA and GT48. Colony formation was irregular and sparse for even the less
diluted cultures. An example of SMCA culture diluted to 1x10-3 can be seen in Figure 2.18.
Positive PCR bands were found from both an agar plug (0.8% plates) and a cotton swab from
the surface of a SMCA inoculated 1.6% plate (Data not shown).
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(10-3)

(10-4)

(10-5)

(10-6)

Figure 2.17 Growth of diluted SMCA on SP4 plates made with 1.6% Noble agar.
Table 2.12 Summary of CFUs from diluted 1 day old cultures on modified SP4 plates with 1.6%
Noble agar.
Dilution
SCMA 30°C
SMCA 37°C
GT48 30°C
GT48 37°C
10-1
TNTC
TNTC
TNTC
TNTC
-2
10
TNTC
TNTC
TNTC
TNTC
10-3
TNTC
TNTC
TNTC
TNTC
-4
10
TNTC
TNTC
TNTC
TNTC
10-5
1.3E+08
1.6E+08
1.6E+08
2.2E+08

Figure 2.18 Growth of diluted SMCA 10-3 on SP4 plates made with 2.4% Noble agar.
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Discussion
As the literature indicates, spiroplasmas adapt to different temperatures and media by changing
their typical growth characteristics (Bove and Saillard, 1979; Konai et al., 1996; Tully et al.,
1983; Whitcomb, 1983). This lab predominantly uses M1D media and therefore needed to
assess the optimal growth conditions for laboratory strains of SMCA and GT48 in order to
properly study their growth behaviors. M1D media has been used for primary isolation and
maintenance of cultures for both S. citri and S. melliferum (Whitcomb, 1983), and these two
spiroplasmas were used for comparison in growth yields.
The temperature range for spiroplasma growth is 5o- 41°C (Konai et al., 1996). These
experiments compare 30°C and 37°C. In a previous study, S. citri had optimal doubling time at
32°C; S. melliferum and S. mirum both had optimal doubling times at 37°C (Konai et al., 1996).
Doubling time was based on color change alone. The literature has evidence that color change
can be a poor indication of growth for SMCA, since it is slow to acidify media and may reach
stationary phase of growth before acidifying the media (Whitcomb, 1980). For this reason, we
chose to use dark field enumeration to monitor the spiroplasma growth. Based on dark field
results, the calculations of organisms per mL are limited to an approximate range of 1x105 to
1x108. Without being able to detect a true beginning point in the log phase of the growth curve,
accurate doubling time cannot be calculated. This limitation in detection of organisms may also
limit the accuracy for the peak of growth to determine when stationary phase begins.
All four strains exhibited significantly (p<0.05) better growth at 30°C based on dark field
enumeration. Detection of the logarimthmic growth phase for S. citri and S. melliferum was
limited before they appeared to move into a stationary phase. GT48 cultures had sporadic
growth at 37oC, and cultures quickly diminished after reaching the high point in our calculation
range. SMCA appeared to grow well at both temperatures, with higher yields at 30oC. This
finding is probably an indication of the laboratory strains’ adaptation to grow at both
temperatures in M1D.
Although an accurate growth curve could not be determined due to the limitations of dark field
microscopy, the death phase can be predicted to start sometime after 7 days for cultures at 37°C
and 14 days for cultures at 30°C, regardless of dilution. For GT48 cultures between 1-7 days,
growth at 37°C was significantly better or the same as growth at 30°C. However, after day 7,
growth at 30°C was significantly better. The same can be said regarding SMCA cultures. This
finding indicates that S. mirum does not have a long stationary phase at 37°C but cultures at 30oC
could sustain high levels of organisms for approximatly 1 week before moving into the death
phase.
The formation of medusa structures has been seen in other spiroplasmas as well. Whitcomb
found that in later stages of S. citri cultures, which probably corresponded to the stationary
phase, aggregates of bodies appeared in which longer forms of spiroplasma were entangled. He
hypothesized that these forms arose by simple aggregation of multiple organisms or from
repeated branching of a single organism (Whitcomb, 1980). After disrupting the aggregation by
vortexing for 10 minutes, the organisms were not killed from this manipulation, since dark field
enumerations post-vortexing were similar to those numbers calculated for a non manipulated
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culture. This method appears to be appropriate for disruption of aggregates in order to get
accurate dark field counts.
SMCA was originally isolated and characterized using embryonated egg cultures (Clark, 1964).
In order to compare the laboratory strains of S. mirum to the literature, the embryonated egg
research techniques from previous reports were repeated. The first step was to optimize the
methods by comparing inoculation site and incubation methods. Yolk sac inoculations followed
by non-rocking incubation of embryonated eggs proved to be the best method for embryonated
egg experiments based on egg viability results. This followed the findings reported by Clark
where the most consistent results were found from yolk sac inoculations compared to allantoic,
amniotic, and chorioallantoic membrane inoculations (Clark, 1964).
The literature states that pathogenicity of spiroplasma can be lost due to repeated passages in
artificial media (Tully et al., 1982a; Whitcomb, 1980). It was necessary to determine if these
laboratory strains had become attenuated after repeated passages in M1D. Overall, SMCAinoculated eggs had a higher death rate than those inoculated with GT48. These findings also
correlate well with results found in literature. Clark (Clark, 1964) found that eggs inoculated
with SMCA died within four to seven days post yolk sac inoculation. Eggs inoculated with
GT48 exhibited a death curve which was delayed and less uniform then that produced by SMCA.
These findings support that the laboratory strains have not been attenuated and still produce
reliable results in embryonated eggs.
The visualization of GT48 and SMCA from embryonated eggs was complicated by the
gelatinous state of the allantoic fluid causing difficulties in dark field microscopy. PCR results
were also inhibited by factors within the egg fluids and could not be used as a reliable method for
presence of the organism. The negative results for observed organisms in non-viable eggs are
not a reliable indicator for positive presence of the organism. A better method for testing for
presence of the organism within non-viable eggs would be passaging the egg fluids into M1D or
SP4.
Knowing that spiroplasma acidifies artificial media, it was speculated that the same would be
true in embryonated eggs. Spiroplasma did appear to lower the pH within the embryonated egg,
however, it was not a significant difference (p 0.05).
Obtaining colony plate counts has been historically difficult for spiroplasmas. Not only do the
organisms vary in their ability to form colonies, but they are also highly affected by agar content
and environmental conditions (Whitcomb, 1980). In experiments conducted by Tully, SMCA
and GT48 produced colonies on 3.5% noble agar SP4 plates (original recipe). Typical colonies
were somewhat diffuse and irregular, and much of their growth occurred within the agar after 14
to 17 days of incubation at 30oC in an atmosphere of 95% N2 and 5% CO2. Similar results were
obtained from plates made with 0.8% noble agar. Following the ATCC SP4 recipe with the
addition of Noble agar (1.6%) produced consistent countable colonies on or near the surface of
the agar. Plates incubated at 37°C did produce a significantly (p 0.05) higher number of CFUs.
It should be noted that plates should be used immediately for best results.
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Whitcomb stated that an effective strategy for obtaining countable colonies was the incorporation
of higher concentrations of agar (Whitcomb, 1983). The addition of excess Noble agar produced
“fried egg” like colonies, which were described as an indication for poor growth conditions
(Whitcomb, 1983). These plates produced a much lower colony count that did not correlate well
with our dark field results.
Conclusion
Growth in M1D media at 30°C proved to be significantly better (p<0.05), yielding higher dark
field counts than cultures at 37°C. Dark field enumeration appears to be limited to a range of
1x105 to 1x108 organisms/mL and therefore an accurate growth curve could not be calculated
using this method. PCR was used to check for growth daily and results were comparable to dark
field counts. Color changes were evident in all dilutions after 7 days, though the more diluted
cultures were less obvious. Embryonated egg results were comparable to that in the literature;
however, the artificial media is better for experimental purposes. The organism is difficult to
detect after egg fatality by both dark field and PCR. PCR results may be skewed due to
inhibitory factors in the egg fluids. Embryonated egg experiments support that the laboratory
strains were not attenuated by multiple passages and still produce similar virulence in
embryonated egg cultures as seen in literature. A method for obtaining colony forming units was
also determined for SMCA and GT48. Following the ATCC SP4 recipe with the addition of
Noble agar (1.6%), S. mirum produced consistent countable colonies on or near the surface of the
agar. Those plates incubated at 37°C yielded higher growth counts and significantly better
growth (p<0.05) than those at 30°C.
Although the media used in these experiments supported spiroplasma growth, other media
should still be explored. Research has been promising for some tissue cultures but none have
been successful. The establishment of a culture system may better elucidate the organism’s
potential hosts and pathogenic nature.
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CHAPTER 3:
EFFECTS OF DISINFECTANTS AND ANTIBIOTICS ON SPIROPLASMA SPP.
Introduction
Mollicutes are a class of bacteria distinguished by the absence of a cell wall. The word
"Mollicutes" is derived from the Latin mollis (meaning "soft" or "pliable") and cutis (meaning
"skin"). They are very small, typically only 0.2–0.3 μm in size and have a very small genome.
Mollicutes are the smallest self-replicating organisms known. They are classified into five
genera: Acholeplasma, Anaeroplasma, Mycoplasma, Spiroplasma and Ureaplasma (Murray and
Schleifer, 1994). All members of the genus Spiroplasma are obligately associated with insects,
either as commensals, pathogens or mutualists (Gasparich, 2002). Spiroplasmas are also plant
pathogens implicated in many economical crop diseases. Spiroplasma mirum, isolated from a
rabbit tick, is the only spiroplasma that has been found to be experimentally pathogenic to
vertebrates (Bove, 1997). Suckling mouse cataract agent (SMCA) represents one of the strains
of S. mirum. As the name describes, SMCA inoculated intracerebrally caused suckling mice to
develop cataracts (Clark, 1964). The organism was able to persist in suckling mice, specifically
in the brain tissues for up to two years (Clark and Karson, 1968). It was able to cross the blood
brain barrier, assumingly without provoking an immune response, and caused a persistent
neurologic infection (Bastian, 2005; Bastian and Jennings, 1984; Clark and Karzon, 1968; Tully
et al., 1984). Due to this observation, it was tentatively included with the slow viruses or chronic
infectious neuropathic agents (Hotchin, 1967). It was implicated as a possible causative agent
for transmissible spongiform encephalopathies (TSEs) (Bastian, 2005).
TSEs encompass a condition that affects humans and a variety of animals with a fatal
neurodegenerative disease and associated neurological clinical signs. The disease presents with
morphological and pathophysiological features that parallel other progressive encephalopathies
such as Alzheimer’s and Parkinson’s disease (Aguzzi and Haase, 2003). Research currently
supports evidence that the agent responsible for TSE is a prion, a small proteinaceous infectious
particle (Prusiner, 1982). The prion is a cell surface glycoprotein (Stahl et al., 1987) with an
unknown function. The pathogenesis of the prion is still widely unknown; however it is accepted
that the normal prion PrPc undergoes some sort of posttranslational modification that converts it
to a pathogenic prion PrPsc. PrPsc is an insoluble and partially protease-resistant isoform that
propagates itself by imposing its abnormal conformation onto other PrPc molecules (Aguzzi and
Calella, 2009). The human prion diseases include Kuru, Creutzfeldt-Jakob disease (CJD),
variant CJD, Gerstmann-Straussler-Scheinker (GSS) disease, and fatal familial insomnia (FFI).
The most common animal TSEs are scrapie, which affects sheep and goats; bovine spongiform
encephalopathy (BSE); and chronic wasting disease (CWD), which affects deer and elk.
The difficulty of inactivating TSE agents first became apparent when sheep developed scrapie
post-vaccination against louping-ill. The vaccine was contaminated with the scrapie agent that
had survived exposure to 0.35% formalin (Taylor et al., 1999). Iatrogenic CJD has been
described in humans in three circumstances: in patients for whom medical equipment was used
during intracranial placement of contaminated electroencephalography electrodes or
neurosurgical procedures; in patients who received hormone therapy with cadaveric human
growth hormone or gonadotropin; and in patients who received an implant of contaminated

41

grafts. All known instances of iatrogenic CJD have resulted from exposure to infectious brain,
pituitary, or eye tissue (Rutala and Weber, 2010). It is generally accepted that BSE was caused
by the transmission of the scrapie agent to bovines via foodstuff. It is now known that the
heating process used in many of the rendering procedures used traditionally to manufacture meat
and bone meal do not completely inactivate BSE or scrapie agents (Taylor et al., 1999).
A multitude of research has been dedicated to determining inactivation procedures for prioninfected tissues. Table 3.1 summarizes the research on effective and ineffective decontamination
procedures (Rutala and Weber, 2010).
Research has also been directed towards determining pre-mortem therapy for TSE infections.
Forloni found that several compounds have been found to antagonize prion propagation in
cellular and/or animal models of disease. These include polyanions, polyene antibiotics, congo
red, iododoxorubicin, tetrapyrroles, branched polyamines, tetracyclines, and modified PrP
peptides. Unfortunately most of these compounds do not cross the blood-brain barrier and are
therefore useless in TSE therapy (Forloni et al., 2002).
Resistance to a variety of chemical and physical disinfectants has been cited as a common factor
between Spiroplasma and TSE infectious agents (Bastian, 2005). Bastian reported that
Spiroplasma can resist exposure to temperatures near boiling, glutaraldehyde and other fixatives
(Bastian, 2005). This chapter will focus on Spiroplasma’s resistance to a variety of physical and
chemical disinfectants as well as antibiotics. Susceptibility will be assessed by dilution and time
of exposure for common laboratory disinfectants, and an antibiotic profile for SMCA, GT48, S.
citri, and S. melliferum will be determined. The information gathered from these experiments
will aid in further evaluating Spiroplasma’s possible role in TSEs.
Spiroplasma’s ability to cross the blood brain barrier, assumingly without provoking an immune
response, will also be further tested in this chapter. Complement plays a role in clearing
invading foreign antigens as part of the body’s innate immune system or is activated by the
adaptive immune system via antibodies. In this chapter, we will test complement’s innate
activity against spiroplasmas using normal goat complement. Antibody-mediated complement
fixation will also be tested using goats hyperimmunized with killed SMCA antigens. This will
help determine the immune systems role in spiroplasma clearance.
Materials and Methods
Bacteria: Two strains of S. mirum were used, SMCA and GT48. Strain SMCA was obtained
from Dr. Frank Bastian, Tulane Medical Center, New Orleans, LA. GT48, ATCC strain #29334,
was obtained from the ATCC Bioresource Center. Spiroplasma melliferrum (ATCC strain BC-3
#33219 Vc161, created on 17MAR90, pass # 3) and S. citri (ATCC strain R8A2 #27556 130
Allen, created on 15Mar95, pass # 4) were also obtained from the ATCC Bioresource Center.
Stock cultures of all strains of spiroplasma (approximately 1x108 organisms per mL) were used
for the following experiments. Cultures were pelleted by centrifugation for 1 hour at 16000xg
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Table 3.1 Efficacy of decontamination procedures for inactivating prions (Rutala and Weber, 2010)
Ineffective (< 3 log reduction)
Effective (> 3 log reduction)

Autoclave at standard exposure conditions
(121°C for 15 minutes)

Autoclave at 121°C–132°C for 1 hour
(gravity displacement sterilizer) or
121°C for 30 minutes (prevacuum sterilizer)
Autoclave at 134°C for 18 minutes
(prevacuum sterilizer)
Autoclave at 134°C for 18 minutes
immersed in water
Sodium dodecyl sulfate, 2%, plus acetic acid, 1%,
plus autoclave at 121°C for 15–30 minutes
Sodium hydroxide (NaOH), 0.09 N or 0.9 N, for 2
hours plus autoclave at 121°C for 1 hour (gravity
displacement sterilizer)

Acetone
Alcohol, 50%–100%
Ammonia, 1.0 M
Boiling
Chlorine dioxide, 50 ppm
Dry heat
Ethylene oxide

Chlorine, 11,000 ppm

Guanidine thiocyanate, 13 M
Formaldehyde, 3.7%
Glutaraldehyde, 5%
Hydrochloric acid, 1.0 N
Hydrogen peroxide, 0.2%, 3%, 6%, 30%, 60%
Hydrogen peroxide gas plasma, Sterrad 100S (ASP)
Iodine, 2%
Microwave
Ortho-phthalaldehyde, 0.55%
Peracetic acid, 0.2%–19%
Phenol/phenolics (concentration variable)
Potassium permanganate, 0.1%–0.8
Sodium dodecyl sulfate, 1%–5%

Copper, 0.5 mmol/L, and
hydrogen peroxide, 100 mmol/L
Hydrogen peroxide, 59%
Vaporized hydrogen peroxide, 1.5–2 mg/L
Hydrogen peroxide gas plasma (Sterrad NX)

Peracetic acid, 0.2%
Phenolic disinfectant (specific formulation), 10.9%
Sodium dodecyl sulfate, 2%, and acetic acid, 1%
Sodium hydroxide, x1 N
Sodium metaperiodate, 0.01 M

Sodium deoxycholate 5%
Radiofrequency gas plasma
Tego (dodecyl-di[aminoethyl]-glycine), 5%
Triton X-100, 1%
Urea, 4–8 M
UV light Ionizing radiation

and resuspended in sterile PBS. Growth of Spiroplasma in M1D media was determined by color
change indicated by phenol red acidification and confirmed by dark field microscopy.
M1D Media: The ingredients for M1D are seen in Table 3.2. Media was filter sterilized
through a 0.2 µm filter and stored at -4oC. Media was heated to room temperature and containers
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were sterilized with 70% ethanol before use to reduce possible bacterial contamination. Once
inoculated with bacteria, media was monitored for growth via dark field microscopy and/or color
change.
Table 3.2 M1D media (yields 300 mLs)
Ingredients
Mycoplasma broth
2.1 g
base
Bacto-Tryptone
1g
Bacto-Peptone
0.8 g
Glucose
0.1 g
Fructose
0.1 g
Sucrose
1g
Sorbitol
7g
Distilled water
70 mL
Schneiders Drosophilia
160 mL
medium
Fetal Bovine Serum
50 mL
Fresh yeast extract
10 mL
(25%)
Phenol Red 0.5%
1.2 mL
Potassium Penicillin
2.5 mL
(100,000 U/ml)
Dark Field Microscopy: A 5 µL culture sample was placed on a clean glass microscope slide,
mounted with a #1.5 cover slip and sealed on all four sides with clear finger nail polish. Slides
were examined with a Ziess Axio Imager A1 microscope (Carl Zeiss, Inc. North America,
Thornwood, NY, USA) equipped with a dark-field top lens condenser 1.2-1.4 and an EC PalnNeoFluar x 100 oil immersion objective (Carl Zeiss, Inc. North America, Thornwood, NY, USA)
with 1.3 iris closed to its lowest setting (0.7).
Disinfectant experiments: Broth dilution and especially microbroth dilution methods for testing
disinfectant or antibiotic susceptibility have been modified for mollicutes. The method employs
spiroplasma media with decreasing disinfectant concentrations, inoculated with a standardized
number of microorganisms in a 96-well microtiter plate (Bebear and Bebear, 2002). The mean
inhibitory concentration (MIC) is defined as the lowest concentration of disinfectant that
prevents a color change at the time when the color in the control without disinfectant has
changed. Turbidity or inappropriate color change in broth control indicates bacterial
contamination. The following experiments will follow these procedures.
100 µL of a specific species of spiroplasma (approximately 1x108 organisms per mL)
resuspended in PBS was placed in all wells of a 96 well plate. 100 µL of disinfectant was then
added to the first vertical column of the microtiter plate. Original concentrations of disinfectants
are indicated in Table 3.2. 100 µL was then transferred through the adjacent row of wells to
create 1:2 dilutions. At set time points (1, 5, 10, 15, 30, and 60 minutes), 20 µL of each dilution
was transferred into 280 µL fresh M1D media in a separate 96 well plate. A row in the plate was
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left with media alone, and the last row was seeded with normal Spiroplasma culture as a positive
control. All transferred cultures were incubated at 30oC for 7 days. Growth was confirmed via
dark field microscopy. A list of disinfectants used can be found in Table 3.3. The same
procedure was followed for all liquid disinfectants. Experiments were duplicated to establish
reproducibility.
For heat lability experiments, 1 mL of Spiroplasma culture resuspended in PBS was placed in a
1-mL centrifuge tube and submerged in a water bath at varying temperatures (45oC, 50oC, 56oC).
For ultraviolet experiments, 1 mL of Spiroplasma culture resuspended in PBS was left in an open
1 mL polystyrene centrifuge tube and placed under a UV light. At set time points(1, 5, 10, 15,
30, and 60 minutes), 20 µL of culture was removed and placed into 280 µL fresh media in a
separate 96 well plate and incubated as above. A row in the plate was left with media alone, and
the last row was seeded with normal Spiroplasma culture as a positive control. For autoclaving
experiments, 1ml of Spiroplasma culture was placed in a glass test tube and autoclaved for 15
minutes at 121ºC. 100 µl of culture was removed prior to autoclaving and placed in 900 µl of
fresh M1D to serve as a control.
Table 3.3 Summary of disinfectants tested for spiroplasma susceptibility
Disinfectant
Range of dilution
Ethanol
70-0.02%
Alcohols
Methanol
100-0.02%
Isopropanol
100-0.02%
Formalin
20-0.002%
Aldehydes
Gluteraldehyde
100-0.02%
Sodium Hypochlorite
5.25-0.001%
Oxidizing Agents Povidone-iodine
100-0.02%
Hydrogen Peroxide
3-0.001%
Solvent
Acetone
100-0.02%
Chlorhexidine
2-0.001%
Sodium Hydroxide (1 Molar)
100-0.02%
Surfactants
SDS
10-0.002%
Roccal-D Plus
100-0.02%
Tris (pH 7)
100-0.02%
Buffers
Tween-20
100-0.02%
Ethylenediaminetetraacetic acid (EDTA) (1 Molar)
100-0.02%
Irradiation
Ultraviolet Light
0-60 minutes of exposure
Autoclave
121oC for 15 minutes
Temperature
Changes
Heat
45oC, 50oC, 56oC
Antibiotic experiments: A fresh 1:100 dilution stock culture was made of each species. 200 µL
of culture was placed in a TREK Diagnostic Systems Sensititre Avian plate, Cleveland, Ohio.
Three wells within the diagnostic plate were not seeded with any antimicrobials to serve as
controls. A list of antimicrobial agents and the ranges tested can be found in Table 3.4. Each
plate was incubated at 30oC for 7 days. Growth was confirmed by dark field microscopy.
Experiments were duplicated to establish reproducibility.
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Table 3.4 Summary of antibiotics used to test spiroplasma susceptibility
Bacteriocidal or
Antibiotic
Mechanism of action
Range (µg/mL)
Bacteriostatic
Inhibits DNA gyrase
Fluorquinolones
Enrofloxacin
2-0.12
Bacteriocidal
Inhibits DNA gyrase
Aminocoumarin
Novobiocin
4-0.5
Bacteriocidal
Penicillin
8-0.5
Inhibit cell wall synthesis
Penicillins
Bacteriocidal
Amoxicillin
16-0.25
Inhibits cell wall synthesis
Cephalorsporins
Cetfiofur
4-0.25
Bacteriocidal
Streptomycin
1024-8
Bind 30S ribosome and inhibit
Aminoglycosides
Neomycin
32-2
Bacteriocidal
protein synthesis
Gentamicin
8-0.5
Aminocyclitols
Tetracyclines

Spectinomycin

64-8

Tetracycline
Oxytetracycline
Erythromycin
Tylosin tartrate

8-0.25
8-0.25
4-0.12
20-2.5

Bacteriostatic
Bacteriostatic

Bind 30S ribosome and inhibit
protein synthesis
Bind 30S ribosome and inhibit
protein synthesis

Lincosamides

Clindamycin

4-0.5

Bacteriostatic

Bind 50S ribosome and inhibit
protein synthesis
Bind 50S ribosome and inhibit
protein synthesis
Bind 50S ribosome and inhibit
protein synthesis

Sulfonamides

Sulfadimethoxine
Sulphathiazole
Trimethoprim/
sulfamethoxazole

256-32
256-32

Bacteriostatic

Inhibits bacterial synthesis of
folic acid

Macrolides

Florfenicol

Bacteriostatic

8-1

Bacteriostatic

2/38-0.5/9.5

Complement experiments: Complement susceptibility tests were conducted on all Spiroplasma
to evaluate its role in the immune system response to spiroplasma. Blood was collected from the
jugular vein of a normal goat in a red top vacutainer tube (no additives). The tubes were
immediately put on ice to preserve complement. Tubes were spun at what speed after icing
overnight, and the complement-preserved serum was removed and stored at -20oC. Blood was
also collected following the same procedures from goats hyperimmunized with killed SMCA
antigen. Previously, two goats were immunized with boiled SMCA antigen. 1 mL of the
solution was mixed with 1 mL of incomplete freund’s adjuvant. The 2 mL mixture was injected
intramuscularly into two different goats. Goats were boosted with 0.5 mL SMCA and 0.5 mL
incomplete freund’s adjuvant 4 and 6 weeks later. To serve as controls, 1 mL of complementpreserved serum from normal goats and hyperimmunized goats was heated in a water bath at
56oC for 1 hour. 500 µL of Spiroplasma culture was mixed with 500 µL of complementpreserved normal serum, 500 µL of complement-preserved hyperimmunized serum, or the 500
µLof the heat inactivated controls. At set time points, 20 uL of culture was removed and placed
into 280 µL fresh media in a separate 96-well plate and incubated as above.
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Results
Disinfectant experiments: Following a two-fold dilution series, the concentration listed in the
results below is the smallest dilution of disinfectant which inhibited spiroplasma growth.
Alcohols: Spiroplasma spp. were susceptible to low levels of alcohol treatment. After 1
minute of exposure to 35% ethanol, all spiroplasma growth was inhibited (Table 3.5).
Methanol and isopropanol were also effective on contact and inhibited growth at 50%
concentration (Table 3.6 and 3.7).
Table 3.5 Concentration of ethanol (70-0.02%) that inhibited spiroplasma growth.
Time
SMCA
GT48
S. melliferum
S. citri
1 minute
35%
35%
35%
35%
35%
35%
35%
35%
5 minutes
35%
35%
35%
35%
10 minutes
35%
35%
35%
35%
15 minutes
35%
35%
35%
35%
30 minutes
35%
35%
35%
35%
60 minutes
Table 3.6 Concentration of methanol (100-0.02%) that inhibited spiroplasma growth
Time
SMCA
GT48
S. melliferum
S. citri
100%
50%
1 minute
50%
50%
50%
50%
50%
5 minutes
50%
50%
50%
50%
50%
10 minutes
50%
50%
50%
50%
15 minutes
50%
50%
50%
50%
30 minutes
50%
50%
50%
60 minutes
25%
Table 3.7 Concentration of isopropanol (100-0.02%) that inhibited spiroplasma growth.
Time
SMCA
GT48
S. melliferum
S. citri
50%
50%
50%
1 minute
50%
50%
50%
50%
5 minutes
25%
50%
50%
25%
50%
10 minutes
50%
50%
25%
50%
15 minutes
25%
50%
25%
25%
30 minutes
50%
25%
60 minutes
12.5%
12.5%
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Aldehydes: Spiroplasmas were susceptible to 3-0.04% formalin (Table 3.8). GT48 was able
to grow in 50% gluteraldehyde, but all other Spiroplasma tested were inactivated by 0.8%
gluteraldehyde or less (Table 3.9).
Table 3.8 Concentration of formalin (20-0.002%) that inhibited spiroplasma growth.
Time
SMCA
GT48
S. melliferum
S. citri
1 minute
0.6%
2.5%
0.3%
0.04%
0.6%
2.5%
0.3%
0.04%
5 minutes
0.6%
2.5%
0.3%
0.04%
10 minutes
0.6%
2.5%
0.3%
0.04%
15 minutes
0.6%
2.5%
0.3%
0.04%
30 minutes
0.6%
2.5%
0.3%
0.04%
60 minutes
Table 3.9 Concentration of gluteraldehyde (100-0.02%) that inhibited spiroplasma growth.
Time
SMCA
GT48*
S. melliferum
S. citri
1.6%
6.2%
1.6%
1 minute
50%
1.6%
1.6%
1.6%
5 minutes
50%
0.8%
1.6%
1.6%
10 minutes
50%
0.8%
1.6%
0.8%
15 minutes
50%
0.4%
0.8%
30 minutes
50%
0.8%
0.8%
60 minutes
0.2%
50%
0.4%
* GT48 survived in all dilutions of Gluteraldehyde.
Oxidizing Agents: The oxidizing agents had a major impact on Spiroplasma growth. Iodine
did not allow growth at even the lowest dilution (0.02%) for any spiroplasma species (Table
3.11). Sodium hypochlorite inhibited growth of all Spiroplasma at very small dilutions
(Table 3.10) as did hydrogen peroxide (Table 3.12)
Table 3.10 Concentration of sodium hypochlorite (5.25-0.001%) that inhibited spiroplasma
growth.
Time
SMCA
GT48
S. melliferum
S. citri*
0.04%
0.006%
1 minute
0.04%
0.003%
0.04%
0.04%
0.006%
0.003%
5 minutes
0.04%
0.04%
0.006%
0.003%
10 minutes
0.04%
0.006%
0.003%
15 minutes
0.02%
0.02%
0.04%
0.003%
30 minutes
0.003%
0.02%
0.04%
0.003%
0.003%
60 minutes
* S. citri had no growth. The lowest dilution tested is listed.
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60 M
30 M
15 M
10 M
5M
1M
Media
Positive
Figure 3.1 Example of 96-well plate used to study the effects of sodium hypochlorite on
spiroplasma growth

Table 3.11 Concentration of povidone-iodine (100-0.02%) that inhibited spiroplasma growth.
Time
SMCA
GT48
S. melliferum
S. citri*
1.6%
0.05%
1.6%
1 minute
0.025%
0.4%
0.05%
0.4%
0.025%
5 minutes
0.4%
0.05%
0.4%
0.025%
10 minutes
0.1%
0.05%
0.1%
0.025%
15 minutes
0.1%
0.1%
0.025%
30 minutes
0.025%**
0.025%
60 minutes
0.025%**
0.025%**
0.025%**
* S. citri had no growth. The lowest dilution tested is listed.
**No growth in the lowest dilution tested.
Table 3.12 Concentration of hydrogen peroxide (3-0.001%) that inhibited spiroplasma growth.
Time
SMCA
GT48
S. melliferum
S. citri
0.09%
0.09%
1 minute
0.09%
0.18%
0.09%
0.09%
0.18%
0.09%
5 minutes
0.09%
0.09%
0.18%
0.09%
10 minutes
0.09%
0.09%
0.18%
15 minutes
0.05%
0.09%
0.09%
0.18%
0.05%
30 minutes
0.09%
0.18%
0.05%
60 minutes
0.05%
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Solvent: Acetone (50%) was effective against Spiroplasma growth (Table 3.13).
Table 3.13 Concentration of acetone (100-0.02%) that inhibited spiroplasma growth.
Time
SMCA
GT48
S. melliferum
S. citri
1 minute
50%
25%
50%
50%
50%
25%
50%
50%
5 minutes
50%
25%
50%
50%
10 minutes
50%
25%
50%
50%
15 minutes
50%
25%
50%
50%
30 minutes
50%
25%
50%
50%
60 minutes
Surfactants: All surfactants tested were able to inhibit spiroplasma growth at low dilutions.
Chlorhexidine (Table 3.14) and SDS (Table 3.16) were able to inhibit most species tested at
all dilutions. Sodium hydroxide, an effective agent for prions, inhibited growth at 3.2% for
all Spiroplasma (Table 3.15). Roccal-D Plus, used around herd animals, was also very
effective, inhibiting growth at dilutions of 0.4% and less (Table 3.17).
Table 3.14 Concentration of chlorhexidine (2-0.001%) that inhibited spiroplasma growth.
Time
SMCA
GT48
S. melliferum
S. citri
0.004%
0.002%
0.008%
0.002%
1 minute
0.002%
0.002%.
0.002%
5 minutes
0.004%
0.002%
0.002%.
0.004%
0.002%
10 minutes
0.002%
0.002%
0.004%
15 minutes
0.001%**
0.002%
0.004%
30 minutes
0.001%**
0.001%**
0.004%
60 minutes
0.001%**
0.001%**
0.001%**
.**No growth in the lowest dilution tested
Table 3.15 Concentration of sodium hydroxide (1 mol) (100-0.02%) that inhibited spiroplasma
growth.
Time
SMCA
GT48
S. melliferum
S. citri
6.2%
6.2%
6.2%
1 minute
3.13%
3.13%
3.13%
6.2%
3.13%
5 minutes
3.13%
3.13%
3.13%
10 minutes
3.13%
3.13%
3.13%
3.13%
1.6%
15 minutes
3.13%
3.13%
3.13%
30 minutes
0.8%
3.13%
3.13%
0.8%
60 minutes
1.6%
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Table 3.16 Concentration of SDS (10-0.002%) that inhibited spiroplasma growth.
Time
SMCA
GT48
S. melliferum
S. citri
0.01%
0.02%
0.005%
1 minute
0.02%
0.005%
0.02%
0.02%
0.005%
5 minutes
0.005%
0.02%
0.02%
0.005%
10 minutes
0.02%
15 minutes
0.002%**
0.01%
0.002%**
0.02%
0.01%
30 minutes
0.002%**
0.002%**
0.02%
0.01%
60 minutes
0.002%**
0.002%**
**No growth in the lowest dilution tested.
Table 3.17 Concentration of Roccal-D Plus (100-0.02%) that inhibited spiroplasma growth.
Time
SMCA
GT48
S. melliferum
S. citri
0.8%
0.4%
1 minute
0.4%
0.1%
0.4%
0.1%
0.8%
0.4%
5 minutes
0.4%
0.1%
0.4%
0.4%
10 minutes
0.4%
0.1%
0.4%
0.4%
15 minutes
0.4%
0.1%
0.4%
30 minutes
0.2%
0.4%
0.1%
0.2%
60 minutes
0.2%
Buffers: Tris (pH 7) and Tween-20 allowed growth for all Spiroplasmas at all dilutions and
all time points (data not shown).
EDTA: EDTA (1 mol) did not inhibit growth of any Spiroplasma strain tested at any dilution
or time point (data not shown).
Irradiation: With the exception of GT48, Spiroplasmas are also susceptible to UV irradiation
after 1 hour (Table 3.18).
Table 3.18 Spiroplasma growth in the presence of ultraviolet irradiation at various times
Time
SMCA
GT48
S. melliferum
S. citri
Growth
Growth
Growth
Growth
1 minute
Growth
Growth
Growth
Growth
5 minutes
Growth
Growth
Growth
Growth
10 minutes
Growth
Growth
Growth
Growth
15 minutes
Growth
Growth
Growth
Growth
30 minutes
Growth
60 minutes
No Growth
No Growth
No Growth
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Temperature: All Spiroplasma species were inactivated following autoclaving at 121ºC,
15 psi (Table 3.19). SMCA was able to survive 1 hour at 40oC and 50oC but only 10
minutes at 56oC (Tables 3.20-3.22). Spiroplasma melliferum and S. citri survived only
30 minutes at both 50oC and 56oC (Tables 3.20-3.22). GT48 was able to survive 1 hour
at all temperatures tested (Tables 3.20-3.22).
Table 3.19 Spiroplasma growth following autoclaving (121o, 15psi)
Time
SMCA
GT48
S. melliferum
15 minutes
No Growth
No Growth
No Growth

S. citri
No Growth

Table 3.20 Spiroplasma growth in the presence of heat (45o C) at various times
Time
SMCA
GT48
S. melliferum
S. citri
Growth
Growth
Growth
Growth
1 minute
Growth
Growth
Growth
Growth
5 minutes
Growth
Growth
Growth
Growth
10 minutes
Growth
Growth
Growth
Growth
15 minutes
Growth
Growth
Growth
Growth
30 minutes
Growth
Growth
Growth
Growth
60 minutes
Table 3.21 Spiroplasma growth in the presence of heat (50o C) at various times
Time
SMCA
GT48
S. melliferum
S. citri
Growth
Growth
Growth
Growth
1 minute
Growth
Growth
Growth
Growth
5 minutes
Growth
Growth
Growth
Growth
10 minutes
Growth
Growth
Growth
Growth
15 minutes
Growth
Growth
Growth
Growth
30 minutes
Growth
Growth
60 minutes
No Growth
No Growth
Table 3.22 Spiroplasma growth in the presence of heat (56o C) at various times
Time
SMCA
GT48
S. melliferum
S. citri
Growth
Growth
Growth
Growth
1 minute
Growth
Growth
Growth
Growth
5 minutes
Growth
Growth
Growth
Growth
10 minutes
Growth
Growth
15 minutes
No Growth
No Growth
No Growth
Growth
No Growth
30 minutes
No Growth
No Growth
Growth
No Growth
No Growth
60 minutes
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Figure 3.2 Examples of cultures growing at 30°C after heat experiments. The center tube
contains SMCA after 1 hour at 56°C. A positive control containing normally incubated bacteria
in media (yellow fluid) is found to the right and was used to help correlate color change. A
negative control of media alone (orange fluid) was heated along with SMCA culture to be sure
that no color change would occur due to the heating process.

Overall Spiroplasma was susceptible to most of the common laboratory disinfectant methods.
Furthermore we found that the majority were effective at very low concentrations and at
immediate contact (<1minute). GT48 was the most resilient of the Spiroplasma tested, showing
growth at higher concentrations and higher temperatures than the other Spiroplasma. Table 3.23
summarizes the smallest percentage of disinfectant positive for Spiroplasma growth and the
contact time required to reach this end point. Table 3.24 summarizes the percentage of
disinfectant positive for Spiroplasma growth after 60 minutes.
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Table 3.23 Minimal inhibitory concentration and time required of disinfectants for spiroplasma.
G: Growth, NG: No growth
Range of
Disinfectant
SMCA
GT48
S. melliferum
S. citri
dilution
70-0.02%
35%
1m
35%
1m
35%
1m
35%
1m
Ethanol
100-0.02%
50%
1m
50%
1m
50%
5m
25%
60m
Alcohols
Methanol
100-0.02%
12.5%
60m
50%
1m
25%
5m
12.5%
60m
Isopropanol
20-0.002%
0.6%
1m
2.5%
1m
0.4%
1m
0.04%
1m
Formalin
Aldehydes
0.2%
60m
G
60
0.8%
30m
0.4%
60m
Gluteraldehyde 100-0.02%
Sodium
5.25-0.001% 0.02% 15m 0.04%
1m
0.002% 30m
NG
1m
Hypochlorite
Oxidizing
Povidone100-0.02%
NG
60m
NG
30m
NG
60m
NG
1m
Agents
iodine
Hydrogen
3-0.001%
0.1%
5m
0.1%
1m
0.18%
1m
0.04%
15m
Peroxide
100-0.02%
50%
1m
25%
1m
50%
1m
50%
1m
Solvent
Acetone
2-0.001%
NG
60m
NG
30m 0.004%
5m
NG
15m
Chlorhexidine
Sodium
100-0.02%
1.6%
60m
3.2%
1m
3.2%
10m
0.8%
30m
Hydroxide
Surfactants
(1 Molar)
10-0.002%
NG
15m 0.02%
1m
0.01%
15m
NG
15m
SDS
100-0.02%
0.4%
1m
0.1%
1m
0.2%
30m
0.2%
60m
Roccal-D Plus
100-0.02%
G
60m
G
60m
G
60m
G
60m
Tris (pH 7)
Buffers
100-0.02%
G
60m
G
60m
G
60m
G
60m
Tween-20
100-0.02%
G
60m
G
60m
G
60m
G
60m
EDTA (1 Molar)
0-60
Ultraviolet
minutes of
G
30m
G
60m
G
30m
G
30m
Irradiation
Light
exposure
Autoclave
Temperature
Changes

Heat

121oC for 15
minutes
45°C
50°C
56°C

NG

-

NG

-

NG

-

NG

-

G
G
G

60m
60m
10m

G
G
G

60m
60m
60m

G
G
G

60m
30m
10m

G
G
G

60m
30m
15m
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Table 3.24 Minimal inhibitory concentration of disinfectant for spiroplasma after 60 minutes
G: Growth, NG: No growth
Range of
Disinfectant
SMCA
GT48
S. melliferum
S. citri
dilution
70-0.02%
35%
35%
35%
35%
Ethanol
100-0.02%
50%
50%
50%
25%
Alcohols
Methanol
100-0.02%
12.5%
50%
25%
12.5%
Isopropanol
20-0.002%
0.6%
2.5%
0.3%
0.04%
Formalin
Aldehydes
0.2%
G
0.8%
0.8%
Gluteraldehyde 100-0.02%
Sodium
5.25-0.001%
0.02%
0.04%
0.002%
NG
Hypochlorite
Oxidizing
Povidone100-0.02%
NG
NG
NG
NG
Agents
iodine
Hydrogen
3-0.001%
0.04%
0.1%
0.18%
0.04%
Peroxide
100-0.02%
50%
25%
50%
50%
Solvent
Acetone
2-0.001%
NG
NG
0.004%
NG
Chlorhexidine
Sodium
100-0.02%
1.6%
3%
3%
0.8%
Hydroxide
Surfactants
(1 Molar)
10-0.002%
NG
0.02%
0.01%
NG
SDS
100-0.02%
0.4%
0.1%
0.2%
0.2%
Roccal-D Plus
100-0.02%
G
G
G
G
Tris (pH 7)
Buffers
100-0.02%
G
G
G
G
Tween-20
100-0.02%
G
G
G
G
EDTA (1 Molar)
0-60
Ultraviolet
minutes of
NG
G
NG
NG
Irradiation
Light
exposure
Autoclave
Temperature
Changes

Heat

121oC for 15
minutes
45°C
50°C
56°C

NG

NG

NG

NG

G
G
NG

G
G
G

G
NG
NG

G
NG
NG
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Antibiotic experiments: Overall we found Spiroplasma to be susceptible to macrolides,
florfenicol, and tetracylcines. They were most affected by bacteriostatic antibiotics that targeted
the 50S ribosome. Spiroplasmas were most susceptible to the macrolide tylosine tartrate that
inhibited growth at all concentrations. Table 3.25 summarizes Spiroplasma susceptibility to all
antibiotics tested.

Table 3.25 Spiroplasma susceptibility to antibiotics.
Range
Antibiotic
S/C Mechanism of action
(ug/ml)
Fluorquinolones
Enrofloxacin
Inhibits DNA gyrase
2-0.12
C
Aminocoumarin
Novobiocin
Inhibits DNA gyrase
4-0.5
C
Penicillin
8-0.5
Inhibit cell wall
Penicillins
C
synthesis
Amoxicillin
16-0.25

Spiroplasma susceptibility
S
G
S.m
S.c
R
R
1
1
R
R
R
R
R
R
R
R
R
R
R
R

Cephalosporins

Cetfiofur

4-0.25

C

Inhibits cell wall
synthesis

R

R

R

R

Aminoglycosides

Streptomycin
Neomycin
Gentamicin

1024-8
32-2
8-0.5

C

Bind 30S and inhibit
protein synthesis

512
R
R

R
R
R

512
R
R

256
R
R

Aminocyclitols

Spectinomycin

64-8

S

R

R

R

R

Tetracycline
Oxytetracycline
Erythromycin
Tylosin tartrate

8-0.25
8-0.25
4-0.12
20-2.5

2
2
0.25
2.5

4
4
0.5
2.5

4
4
2
2.5

4
2
0.5
2.5

2

4

R

R

0.5

0.5

4

1

R
R

R
R

R
R

R
R

R

R

R

R

Tetracyclines
Macrolides

Sulfonamides

S

8-1

S

Clindamycin

4-0.5

S

Sulfadimethoxine
Sulphathiazole

256-32
256-32
2/380.5/9.5

Florfenicol
Lincosamides

S

Trimethoprim/
sulfamethoxazole

S

Bind 30S and inhibit
protein synthesis
Bind 30S and inhibit
protein synthesis
Bind 50S and inhibit
protein synthesis
Bind 50S and inhibit
protein synthesis
Bind 50S and inhibit
protein synthesis
Inhibits bacterial
synthesis of folic acid

Antibiotics are listed in their categories and the different antibiotics that were tested. The range
of antibiotics is listed as well as their mechanisms of action. Bactericidal and bacteriostatic are
indicated with C (bacteriocidal) and S (bacteriostatic). The lowest concentration of antibiotic
that inhibited growth is listed for each Spiroplasma. Those antibiotics that allowed sprioplasma
growth at all levels of antibiotic tested are indicated with an R for resistant. Three different
species of Spiroplasma were tested: S. mirum’s (S) SMCA; S. mirum’s (G) GT48; (S.m) S.
melliferum; and (S.c) S.citri.
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Complement experiments: Spiroplasma spp. were not susceptible to normal goat complement
(Table 3.26). All three species were susceptible to goat complement following opsonization with
hyperimmune serum (Table 3.27). Spiroplasma spp. grew in all heat inactivated complement
controls (data not shown).
Table 3.26 Spiroplasma growth in the presence of normal goat complement
Time
SMCA
GT48
S. melliferum
S. citri
Growth
Growth
Growth
Growth
1 minute
Growth
Growth
Growth
Growth
5 minutes
Growth
Growth
Growth
Growth
10 minutes
Growth
Growth
Growth
Growth
15 minutes
Growth
Growth
Growth
Growth
30 minutes
Growth
Growth
Growth
Growth
60 minutes
Table 3.27 Spiroplasma growth in the presence of hyperimmunized goat complement
Time
SMCA
GT48
S. melliferum
S. citri
Growth
Growth
Growth
Growth
1 minute
Growth
Growth
Growth
Growth
5 minutes
Growth
Growth
Growth
Growth
10 minutes
Growth
Growth
Growth
Growth
15 minutes
30 minutes
No Growth
No Growth
No Growth
No Growth
60 minutes
No Growth
No Growth
No Growth
No Growth

Discussion
The lack of cell wall in spiroplasmas explains most of the susceptibility seen for the disinfectants
tested. However, GT48 was resistant to higher dilutions of many of the disinfectants as well as
higher temperatures and requires more testing to determine its virulence factors. In general, the
spiroplasmas were susceptible to most disinfectants that are ineffective for prions.
Alcohols are a common disinfectant used in everyday laboratory use. They have limited residual
activity due to evaporation, which results in brief contact times unless the surface is submerged,
and have a limited activity in the presence of organic material. Alcohols are most effective when
combined with purified water to facilitate diffusion through the cell membrane; 100% alcohol
typically denatures only external membrane proteins. Ethyl alcohol (C2H5OH), isopropyl
alcohol ((CH3)2CHOH), and methanol (CH3OH) cause membrane damage, rapid denaturation of
proteins, and subsequent interference on metabolism resulting in cell lysis. Alcohols are
generally effective against vegetative bacteria, viruses, and fungi (McDonnell and Russell,
1999). They are reported to be an ineffective disinfectant for prions at concentrations of 50100% (Rutala and Weber, 2010). Spiroplasma, however, were susceptible to low levels of
alcohol treatment. After 1 minute of exposure to 35% ethanol, all spiroplasma growth was
inhibited. Methanol and isopropanol were also effective on contact and inhibited growth at 50%
concentration. This can be attributed to the membrane damage and rapid denaturation of
proteins that alcohols cause on contact. This study correlates well with Stanek’s findings in
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1981. He reported that S. citri, S. melliferum, and SMCA were susceptible to ranges of ethanol
from 40-20% over a 40 minute time period (Stanek et al., 1981).
Aldehydes, such as formaldehyde (CH2O) and glutaraldehyde (CH2(CH2CHO)2), have wide
microbiocidal activity and are sporocidal and fungicidal. Formaldehyde mixed in an aqueous
solution is commonly referred to as formalin. Both of these aldehydes kill cells quickly by
crosslinking proteins and may be used as a disinfectant or fixative for infected tissues.
Formaldehyde (3.7%) and gluteraldehyde (5%) have been shown to be ineffective against prion
fixation. Spiroplasmas were susceptible to 3-0.02% formalin which agrees with Clark and
Stanek’s publications reporting inactivation of Spiroplasma after exposure to 2-0.03% formalin
(Clark, 1964; Stanek et al., 1981). GT48 was able to grow in 50% gluteraldehyde (see Table
3.28), and Bastian also reported Spiroplasma could resist gluteraldehyde (Bastian, 2005). All
other Spiroplasma were inactivated by 0.8% gluteraldehyde or less. This also correlates with
Stanek’s findings for gluteraldehyde (inactivation range: 0.5-0.06%) (Stanek et al., 1981).
Formaldehyde appears to be the more suitable fixative for spiroplasma-infected tissues due to its
ability to cross link proteins and kill the organisms. Gluteraldehyde was less effective, especially
for GT48, and more research is needed to determine the strain’s survival factors.
Oxidizing agents act by oxidizing the cell membrane of microorganisms, which results in a loss
of structure and leads to cell lysis and death. A large number of disinfectants function in this
way. Sodium hypochlorite (NaClO), povidone-iodine, and hydrogen peroxide (H2O2) are
examples of oxidizing agents that were studied in this paper. Household bleach, sodium
hypochlorite normally sold as a 5.25% concentration, is used at 10% solution in laboratory
conditions to keep harmful corrosive effects to a minimum. It is effective against 99% of
bacteria, viruses and some types of mold (Estrela et al., 2002). Povidone-iodine contains 9-12%
available iodine (I2) and is effective against bacteria, viruses, fungus, and protozoan cysts
(Reimer et al., 1998). Hydrogen peroxide, diluted to 3%, is a common disinfectant in
laboratories and households. These agents had a major impact on Spiroplasma survival. Iodine
did not allow growth at even the lowest dilution (0.02%) for any spiroplasma species. Sodium
hypochlorite inhibited growth of all Spiroplasma at very small dilutions (0.04%) as did hydrogen
peroxide (0.1%). The oxidizing agents’ efficacy against Spiroplasmas is most likely attributed to
the lack of a cell wall and easy access for oxidation of the cell membrane. Prions can be
inactivated by hydrogen peroxide but only at higher percentages (59%). They are not affected by
iodine (2%) (Rutala and Weber, 2010).
A variety of surfactants are used in the laboratory for disinfecting glassware and work surfaces.
Chlorhexidine (N',N'''''-hexane-1,6-diylbis[N-(4-chlorophenyl) (imidodicarbonimidic diamide))
is commonly used as a topical antiseptic. It works by damaging the outer cell layers and attacks
the bacterial cytoplasmic or inner membrane ((McDonnell and Russell, 1999). Sodium
hydroxide (NaOH), also known as lye, is a caustic cleaning agent. Its mechanism of action is
poorly understood, but it is effective against most bacterial agents. Sodium dodecyl sulfate
(SDS) (C12H25SO4Na) is an anionic surfactant used in many cleaning agents. The mode of action
is attributed to the positive charge, which forms an electrostatic bond with negatively charged
sites on microbial cell walls. Those electrostatic bonds create stress in the cell wall, leading to
cell lysis and death. (Simoes et al., 2006). Roccal (Didecyl dimethyl ammonium chloride 9.2%,
Alkyl (C12, 61%; C14, 23%; C16, 11%; C18, 2.5%; C8 & C10, 2.5%), dimethyl benzyl
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ammonium chloride 9.2%, Alkyl (C12, 40%; C14, 50%; C16, 10%) dimethyl benzyl ammonium
chloride 4.6%, bis-n-tributyltin oxide 1.0%, Inert Ingredients: 76.0%) is a commercial cationic
surfactant. It is a bactericide, fungicide, and virucide for veterinary, laboratory animal, kennel
and animal breeder facilities. It is also a residual bacteriostat and inhibits bacterial growth on
moist surfaces and contains rust corrosion inhibitors (Drugs.com). All surfactants tested were
able to inhibit spiroplasma growth at low dilutions. Chlorhexidine and SDS were able to inhibit
most species tested at all dilutions. Sodium hydroxide, an effective agent for prions, inhibited
growth at 3.2% for all spiroplasma. Roccal, used around veterinary operations and herd animals,
was also very effective inhibiting growth at dilutions of 0.4% and less. Surfactants’ efficacy for
Spiroplasma, like the oxidizing agents, is also attributed to their attack on the outer cell layers,
leading to cell lysis and death.
Acetone is an organic compound with the formula (CH3)2CO. In the laboratory, acetone is used
as a polar aprotic solvent in a variety of organic reactions, such as SN2 reactions. It is typically
the solvent of choice for cleaning purposes of laboratory glassware because of its low cost and
volatility (McDonnell and Russell, 1999). Acetone (50%) was effective against Spiroplasma
survival, due to its quick denaturing properties. It is not effective at any percentage for prion
inactivation.
Tris ((HOCH2)3CNH2) and Tween-20 are common compounds found in many laboratory buffers.
It has reported that Tris inhibits a number of enzymes; and therefore, it should be used with care
when studying proteins. (Desmarais et al., 2002). EDTA is a chelating agent that is mainly used
to sequester metal ions in aqueous solution. Animal experiments frequently use blood collecting
tubes that contain EDTA as an anticoagulant. As a precaution, dilutions of EDTA were also
used in the disinfectant studies to be sure that there was no interference in spiroplasma recovery.
Spiroplasma spp. were able to grow in the presence of all concentrations of Tris, Tween, and
EDTA, supporting the presumption that all other experiments with these compounds will not be
affected by their use. EDTA has also been suggested as a disrupting agent for biofilms. S. citri
has the potential to create a biofilm because it uses the phosphoenolpyruvate:phosphotransferase
system (PTS) (Bove et al., 2003). Although we did not test the efficacy of EDTA’s ability to
disrupt Spiroplasma biofilms, our results indicate that it will not cause Spiroplasma death.
When subjected to changing temperatures, various bacteria have different susceptibilities.
Spiroplasma have been reported to grow at temperature ranges from 5-43oC (Konai et al., 1996).
Konai also found that SMCA had no color change at 43oC, but slow growth may have occurred
without acidifying the media. SMCA was able to survive 1 hour at 40oC and 50oC but only 10
minutes at 56oC. S. melliferum and S. citri survived only 30 minutes at both 50oC and 56oC.
GT48 was able to survive 1 hour at all temperatures tested. The lack of cell wall is a reasonable
explanation for the vulnerability to higher temperatures. GT48’s ability to survive at the higher
temperatures is another reason for further testing of its resistant properties. Prions are able to
sustain a wide range of dry heat temperatures (Rutala and Weber, 2010).
An autoclave is used for sterilization purposes in many laboratories. It works by subjecting
items placed inside to high pressure steam at 121 °C for 15–20 minutes depending on the size of
the load and the contents. This inactivates all bacteria, viruses, spores, and fungi. Its efficacy
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against prions has not been proven. All Spiroplasma spp. were inactivated following
autoclaving, another example of their vulnerability to high temperatures.
Ultraviolet lamps are used to sterilize workspaces and tools used in biology laboratories and
medical facilities. UV light at germicidal wavelengths causes adjacent thymine molecules on
DNA to dimerize; if enough of these defects accumulate on a microorganism's DNA, its
replication is inhibited, thereby rendering it harmless. With the exception of GT48, Spiroplasmas
are also susceptible to UV irradiation after 1 hour. UV irradiation is ineffective for GT48 as well
as prions. GT48’s resistance to UV irradiation gives further evidence for protective mechanisms
not seen in the other spiroplasmas tested.
Spiroplasma’s lack of cell wall was a contributing factor to its susceptibility to many of the
disinfectants tested, but it is a survival factor against many of the antibiotics used in today’s
therapies. Mollicutes’ lack a cell wall that makes them innately resistant to all antimicrobials
which target the cell wall. These antimicrobials include polymyxins, sulfonamides,
trimethoprim, nalidixic acid, and rifampin (Bebear and Bebear, 2002). With this explanation, the
resistance found for the penicillins and cephalosporins tested was not surprising. Although
results in this study agreed with the research for resistance to sulfonamides and trimethoprim, in
1984 Bastian found trimethoprim/sulfamethoxazole (TMP/SMX) inhibited clinical and
pathological signs in SMCA-inoculated suckling rats. Suckling rats received 200 mg/kg SMX
and 40 mg/kg TMP in 5%sterile dextrose by IV infusion from day 5-15 post SMCA-inoculation.
Rats were followed to day 25 of the infection. The use of TMP/SMX treatment reduced the
mortality rate significantly. Spiroplasma was recovered from TMP/SMX treated rats, but the
titers were significantly lower (Bastian et al., 1989). Bastian did report that this data disagreed
with their preliminary in vitro findings. He went on to suggest that mortality was not an
appropriate end point and that only viability titers in the brain should be considered.
Spiroplasma was also resistant to the aminoglycosides neomycin and gentamicin, and the
aminocyclitols spectinomycin. Aminoglycosides are bactericidal antibiotics that are used in the
treatment of infections caused by Gram-negative aerobes. They bind to the 30S ribosome and
inhibit the rate of protein synthesis and the fidelity of messenger ribonucleic acid (mRNA)
translation, resulting in the synthesis of abnormal proteins. Aminoglycoside uptake by bacteria
involves an energy-dependent step that is oxygen-linked. Therefore uptake is inhibited by an
anaerobic or acidic environment. Streptomycin represents one of the oldest members of this
group. Neomycin, another aminoglycoside, is used to treat enteric infections and topically to
treat skin, ear, and eye infections. Gentamicin and kanamycin are extended-spectrum
aminoglycosides that are used for the treatment of septicemia and infections of the skin,
respiratory tract, ear, eye and urinary tract. Aminocyclitols are chemically related to the
aminoglycocides. They also bind to the 30S ribosome and inhibit protein synthesis. Unlike
aminoglycosides, they are bacteriostatic. They are effective against Gram-negative and
Mycoplasma bacteria. Spectinomycin is an aminocyclitol used for treatment of enteric and
respiratory disease (Papich, 2007). These antibiotics have been used for treatment of other
genera of mollicutes, the Mycoplasma. Resistance was also found when different concentrations
of the broad-spectrum antibiotics kanamycin and novobiocin failed to inhibit the multiplication
of SMCA in chick embryos and rabbit lens organ cultures (Bastardo et al., 1974; Schwartz and
Elizan, 1972).
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Spiroplasmas, with the exception of GT48, were susceptible to streptomycin, one of the oldest
members of the aminoglycosides. This antibiotic works on the 30S ribosome as do the
tetracyclines. Tetracyclines are bacteriostatic inhibitors of a broad spectrum of bacteria
including, rickettsia, spirochetes, chlamydiae, mycoplasmae, and some protozoa. They inhibit
bacterial protein synthesis by binding to the 30S ribosome and preventing attachment of the
aminoacyl transfer ribonucleic acid (tRNA) to the mRNA-ribosome complex. They block the
addition of amino acids to the growing peptide chain. Tetracyline and oxytetracycline are used
in the treatment of local and systemic bacterial, chlamydial, rickettsial, and protozoal infections
(Papich, 2007). All three species of Spiroplasma were also susceptible to tetracyclines in this
study. However, in vivo, tetracycline did not protect suckling rats against SMCA-induced
cataracts when inoculated (50 µg/animal, repeated 4 days pi) at time of SMCA inoculation or 4
hours prior (Clark, 1974). Rats born to mothers given tetracycline in drinking water
(approximately 500 µg/ml) prior to parturition and during the nursing period were not protected
against SMCA-induced cataracts (Clark, 1974). Tetracyclines have been studied as possible
therapy for TSE infections. Tetracyclines interact with aggregates obtained by synthetic PrP
peptides or pathological PrP (PrPsc) extracted from TSE brains, and they destabilize the structure
of amyloid fibrils, reducing their resistance to digestion by proteinase K. Tetracyclines also
interact with peptide oligomeric structures and inhibit the protein misfolding associated with
PrPsc formation (Forloni et al., 2002).
There were mixed reactions for Spiroplasma susceptibility to enrofloxacin and florfenicol.
Enrofloxacin is a fluoroquinolone that inhibits bacterial DNA gyrase. In vivo, it is distributed
throughout the CNS, bone, and prostate and has broad spectrum bactericidal effects on most
bacteria. Florfenicol is a thiamphenicol derivative bacteriostatic agent that also binds to the
bacterial 50S ribosome unit to inhibit peptide bond formation and protein synthesis. It has broad
spectrum against most anaerobic bacteria and Mycoplasmas and is used for respiratory, CNS,
and ocular infections (Papich, 2007). S. melliferum and S. citri were susceptible to enrofloxacin.
SMCA and GT48 were susceptible to florfenicol. Both of these antibiotics can reach high
intracellular concentrations, which may be an advantage for spiroplasma infections.
Novobiocin is an aminocoumarin antibiotic that is a very potent inhibitor of bacterial DNA
gyrase. It targets a different site on DNA gyrase than that of the flouroquinolones, targeting the
GyrB subunit of the enzyme involved in energy transduction. Novobiocin as well as the other
aminocoumarin antibiotics act as competitive inhibitors of the ATPase reaction catalysed by
GyrB. It is bacteriocidal and is used predominantly for staphylococcal infections(Papich, 2007).
Unlike florfenicol, all Spiroplasmas were resistant to novobiocin.
Spiroplasmas, like Mycoplasmas are susceptible to macrolides and lincosamides. Macrolides are
bacteriostatic antibiotics that work primarily against Gram-positive bacteria and Mycoplasma.
They inhibit bacterial protein synthesis by binding to the 50S ribosome, preventing translocation
of amino acids to the growing peptide chain. Erythromycin, a macrolide, is used as an
alternative to penicillin for the treatment of infections caused by Gram-positive bacteria.
Tylosin, another macrolide, is used for the treatment of local and systemic infections caused by
mycoplasma, Gram-positive bacteria, and some Gram-negative pathogens. Lincosamides
represent another group of antibiotics that inhibit protein synthesis by binding to the 50S
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ribosome. They are also bacteriostatic and are active against Gram-positive bacteria,
Toxoplasma, and Mycoplasma species. Clindamycin, a lincosamide antibiotic, is used for
periodontal disease, osteomyelitis, dermatitis, and deep soft tissue infections caused by Grampositive bacteria (Papich, 2007). Kotani (Kotani et al., 1986)Kotani, Phillips et al. 1986) found
that a combination of tylosine (30 µg/ml) and gentamycin (50 µg/ml) inhibited the
transformation of NIH-3T3 and CV-1 cells by SMCA. Furthermore, cells with history of
spiroplasma infection were negative for the bacteria after the addition of these antibiotics and
tylosine appeared to be the active inhibiting compound in that experiment.
Spiroplasma spp. were not adversely affected by normal goat complement showing that they do
not activate the alternative pathway of complement. All three species were susceptible to
SMCA-hyperimmunized goat serum in the presence of complement. This indicates that
complement mediated lysis does occur via activation of the classical pathway. This provides
evidence that an acquired immune response is required for killing of the organism by
complement.
Conclusion
Although Spiroplasma are similar to prions in their persistence in neurologic tissues,
Spiroplasma do not share the same resistant properties as prions. A comparison of efficacy for
the disinfectants against Spiroplasma and prions can be seen in Table 3.28. The three species of
Spiroplasma tested were susceptible to minimal dilutions of common laboratory disinfectants.
They were also susceptible to many of the antibiotics in use for other mollicutes. We did find
strain differences in S. mirum in that GT48 was more resistant to many of the disinfectants and
antibiotics tested. More research is needed to determine if this resistance is associated with any
virulence factors it may possess.
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Table 3.28 Comparison of disinfectant efficacy against Spiroplasma and prions.
All disinfectants that were found to inhibit spiroplasma are indicated with effective. For a select
few, all species of Spiroplasma were inhibited with the exception of GT48. These disinfectants
are indicated with (GT48).
Disinfectant
Spiroplasma
Prions
Ethanol 70%
Effective
Ineffective
Alcohols
Methanol
Effective
Ineffective
Isopropanol
Effective
Ineffective
Formalin 3%
Effective
Ineffective
Aldehydes
Gluteraldehyde 50%
Effective (GT48)
Ineffective
Sodium Hypochlorite
Effective
Not tested
Oxidizing Agents
Povidone-iodine 2%
Effective
Ineffective
Hydrogen Peroxide 3%
Effective
Ineffective
Solvent
Acetone
Effective
Ineffective
Chlorhexidine
Effective
Ineffective
Sodium Hydroxide
Effective
Effective
Surfactants
SDS 5%
Effective
Ineffective
Roccal
Effective
Not tested
Irradiation
Ultraviolet Light
Effective (GT48)
Ineffective
Autoclave
Effective
Ineffective
Heat 45oC
Ineffective
Ineffective
Temperature
o
Changes
Heat 50 C
Ineffective
Ineffective
Heat 56oC
Effective (GT48)
Ineffective
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CHAPTER 4:
CLINICAL SIGNS AND PATHOLOGY OF SPIROPLASMA MIRUM SUCKLING
MOUSE CATARACT AGENT IN SMALL RUMINANTS
Introduction
Spiroplasma mirum is the only spiroplasma that has been found to be pathogenic to vertebrates
(Bove, 1997). As the name describes, Suckling Mouse Cataract Agent (SMCA) when inoculated
intracerebrally (IC) caused suckling mice to develop cataracts (Clark, 1964). The organism was
able to persist in suckling mice, specifically the brain tissues, for up to two years (Clark and
Karson, 1968). Due to this observation, it was tentatively included with the slow viruses or
chronic infectious neuropathic agents (Hotchin, 1967). When inoculated into suckling rats, 70%
developed cataracts and 36% developed mild to severe hydrocephalus (Elizan et al., 1972). The
organism causes death between four to seven days post inoculation in seven day old
embryonated eggs (Clark, 1964). In day-old chicks inoculated IC or subcutaneously (SQ), S.
mirum caused death within five days (Clark, 1974). When inoculated IC into day old hamsters,
CNS signs and severe weight loss were observed (Kirchhoff et al., 1981). Death and severe
microophthalmia were seen in rabbits inoculated IC less than twenty-four hours after birth. No
clinical signs were seen when S. mirum was inoculated into adult mice, roosters, hamsters,
rabbits, guinea pigs, and rhesus monkeys (Clark, 1974).
The organism’s persistence for long periods of time within the brains of animals led researchers
to categorize SMCA as a “slow virus.” This family included the infectious agent for scrapie in
sheep and the agent of Kuru in man (Schwartz and Elizan, 1972). Tully suggested that this
organism could be related to the causative agent of scrapie which had not yet been identified
(Tully et al., 1976). In 1979 Bastian reported spiral membranous inclusions seen by electron
microscopy in brain biopsy tissues from a patient with Creutzfeldt-Jakob disease (CJD) (Bastian,
1979). Following this initial report of spiroplasma-like inclusions in CJD tissues, Reyes
published two case reports of patients that were suspected of CJD with similar findings. Electron
microscopy revealed numerous membrane-bound vacuoles within the cell bodies of neurons and
astrocytes. Elongated, spiral, membranous inclusions were occasionally present within cortical
cell processes, as well as in synaptic terminals (Reyes and Hoenig, 1981). Reyes also reported
that transmission of CJD to spider monkeys was successful from brain tissues of one of these
reported patients by Dr. D. C. Gajdusek and C. J. Gibbs. In 1980 Gray reported a case of CJD to
have spiral membranous inclusions, indicative of spiroplasma, with five to eight twists seen via
electron microscopy (Gray et al., 1980). In 1981 Bastian reported two more cases of CJD with
similar spiral-like inclusions seen through electron microscopy (Bastian et al., 1981).
Further research was conducted to show similarities between the transmissible agent of CJD and
spiroplasma. Bastian reported that the tissue response to experimental spiroplasma infection in
the suckling rat brain resembles the spongiform degenerative brain diseases of both man and
other mammals. The degenerative changes are localized to the gray matter, as seen in CJD cases
(Bastian et al., 1984). The optimal growth temperature for S. mirum and other spiroplasma
isolates was 37ºC, suggesting that spiroplasma could survive in a mammalian host (Bastian,
2005; Konai et al., 1996). The organism’s proven ability to produce an acute or
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Table 4.1 Summary of Spiroplasma mirum experimentally infected animals
Species

Age

Route

Death

Disease

Chicks

<24 h
<24 h
<96 h

IC
SQ
IC

4 days pi
5-6 days pi
Rarely

>5 days
<96 h
<96 h
Adult

IC
IP
IV
IC

No
No
No
No

Yellow livers and
swollen spleens
Cataracts 1
Stunting
Death
None
None
None
None

Rats

<96 h
<24 h

IV, IN, IP, cornea
IC
SQ/IP4

Yes
No

Deer Mouse
Roosters
Hamsters

Adult
Adult
<24 h

SQ
IM
IC

No
No
Variable

Rabbits

Adult
<24 h

IV
IC

No
12 days

Adult

IV, SQ
Scarified cornea
IP, IM, SQ, cornea
IP
IP
IV, SQ, cornea

No
No
No
No
No
No

Mice

Guinea Pigs
Box Turtle
Opossum
Rhesus Monkey

Adult
Adult
Adult
Adult

Cataracts 3
Cataracts
Weight loss
Alopecia
None
None
CNS signs
Dramatic loss of weight
Runting
None
Death
Severe microphthalmia
None
Ocular lesion
None
None
None
None

Persistence of
organism
NT
NT
827 days

Ref

133 days
9 days2
NT
497 days

(Clark and Karson, 1968)
(Clark and Karson, 1968)
(Clark and Karson, 1968)
(Clark and Karson, 1968)

NT
60 days
50 days

(Clark, 1974)
(Clark, 1974)
(Clark and Karson, 1968)

(Clark, 1974)
(Bastian et al., 1984)
(Bastian et al., 1987b)

NT
NT
NT

(Clark and Karson, 1968)
(Clark, 1974)
(Kirchhoff et al., 1981)

NT
12 days

(Clark, 1974)
(Kirchhoff et al., 1981)

NT
AB negative
NT
NT
NT
NT

(Kirchhoff et al., 1981)
(Clark, 1974)
(Clark, 1974)
(Clark and Karson, 1968)
(Clark and Karson, 1968)
(Clark, 1974)

IC: Intracereberal, SQ: Subcutaneous, IP: Intraperitoneal, IV: Intravenous, IN: Intranasal, IM: Intramuscular, NT: Not tested
1 Cataracts were the most common clinical manifestation of SMCA inoculation
2 Organism was not recovered from brain or eye tissues but was found in liver-spleen suspension
3 Cataracts in suckling rats were more severe with a higher inoculation levels
4 Rats were inoculated with S. mirum strain GT48

65

persistent brain infection in small mammals was also used as evidence. Subsequent studies have
shown some resistance of spiroplasma organisms to chemical factors with some resemblance to
the resistance patterns seen in the transmissible agent of CJD (Bastian, 2005). Bastian concluded
that the size and membranous nature of spiroplasma would best fit with the data regarding the
elusive CJD agent (Bastian et al., 1984).
In 1987 a scrapie-associated fibril was identified as a consistent finding and possible infectious
unit of the transmissible spongiform encephalopathies (TSEs). Cross reactions with this fibril to
S. mirum fibril proteins supported evidence of an association between spiroplasma and TSEs
(Bastian et al., 1987a). In 2001 Bastian and Foster reported the presence of spiroplasma
ribosomal DNA in CJD and scrapie-infected brains (Bastian and Foster, 2001). In 2004 eight of
ten scrapie infected brains, five of seven CWD infected brains, and two of two CJD brains were
found to be positive for S. mirum via southern blotting of PCR products (Bastian et al., 2004).
PCR products obtained from the scrapie, CWD, and CJD cases had 99% homology with
published S. mirum 16S rDNA sequences (Bastian et al., 2004). In this study, it was reported
that the mode of DNA extraction was critical. The most reliable method involved initial
solubilization with guanidine thiocyanate followed by phenol/chloroform extraction (Bastian et
al., 2004). Southern blotting was also acknowledged as a more sensitive method of detection,
revealing spiroplasma DNA where PCR product was not readily apparent (Bastian et al., 2004).
In 2005 Bastian (Bastian, 2005) cultivated a spiroplasma from homogenates of CWD and scrapie
infected brains. The brains were homogenized in SP4 media and then inoculated into eight day
old embryonated eggs. Allantoic fluids from the inoculated eggs were then passaged into SP4
media and incubated for sixteen days at 37ºC. Evidence of spiroplasma growth was found via
phase microscopy, electron microscopy, and PCR. DNA sequence analysis showed 98%
homology with S. mirum but revealed nucleotide substitutions unlike any known spiroplasma
strain. The isolates from this experiment were later inoculated into neonatal goats and sheep
(Bastian et al., 2007). No clinical signs were seen but all brains had evidence of spongiform
changes. At eleven months post inoculation, one goat and one sheep had severe cerebella and
hippocampal spongiform degeneration with neuronal vacuolization in the brain stem. All other
animals were reported to have spongiform changes at a lesser degree. It was noted that the
intraneuronal vacuoles in the cerebella cortex and brain stem seen in the Spiroplasma spp.
inoculated ruminants were identical to lesions typical of naturally occurring TSE (Bastian et al.,
2007).
In 2007 Bastian et al. (Bastian et al., 2007) induced spongiform encephalopathy in neonatal deer
inoculated intracerebrally with SMCA. Three of four deer developed clinical signs of
neurological deterioration between 1.5 months and 5.5 months post inoculation. One deer
showed signs of hydrocephalus, while all others were grossly normal. Histological sections of
all deer showed spongiform encephalopathy in the cerebral cortex, cerebella cortex, and the brain
stem. Severity of neuropathology was noted as incubation time increased. In the same
publication, sheep were inoculated intracerebrally with varying dilutions of SMCA. No clinical
signs were noted, but spongiform encephalopathy was seen histologically. Severity of lesions
was decreased as the dosage of the inoculums decreased. Neonatal goats were also inoculated
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intracerebrally with SMCA. After five months no clinical signs were seen and only minimal
vacuolization was noted histologically.
In order to compare natural TSE infections to Spiroplasma-induced disease, a long term animal
model was established. It has been proven that the mouse model does not always accurately
portray a natural infection and so the ruminant model was chosen for disease establishment.
Goats are known for multiple births, ease of handling, and have also been used for scrapie
research; for these reasons, a herd of research goats were used for experiments with S. mirum.
Neonatal goats were inoculated intracerebrally with SMCA and monitored for clinical signs for
two years. At the end of the experiment, various tissues were collected and examined for
pathology and persistence of the organism.
Five month old deer were also inoculated and monitored for clinical signs. Seven months postinoculation, various tissues were collected and examined for pathology and persistence of the
organisms. Information from this experiment was used to compare to Bastian’s 2007 neonatal
deer experiment (Bastian et al., 2007).
In order to test possible routes of transmission, experiments were conducted with various
inoculation routes of SMCA in neonatal goats. Intravenous (IV) and intradermal (ID) routes
were used as possible vector routes to establish a mode of transmission. Goats were monitored
for four months for clinical signs and persistence of the organism via various tissues. After four
months, tissues were collected and examined for pathology.
Since dose-dependent variations have been reported, pathology and clinical signs seen postSMCA inoculations of higher concentrations were compared. SMCA cultures were concentrated
ten times the normal and inoculated into neonatal goats. Goats were monitored for four months
for clinical signs and persistence of the organism via various tissues. After four months, various
tissues were collected and examined for pathology.
Materials and Methods
SMCA: SMCA strain of S. mirum, courtesy of Dr Gail Gasparich, Towson University,
Baltimore, MD, USA, was used for the inoculums in all experiments and had undergone multiple
passages in M1D broth. SMCA was grown to log phase (Bastian et al., 1984), aliquoted into 1
mL portions mixed 50/50 with sterilized 30% glycerol resulting in a 15% glycerol mixture and
frozen at –80ºC. For all following experiments, a stock of SMCA (approximately 1x108
organisms per mL) was made by multiple passages at a 1:100 dilution rate into M1D and frozen
at -80ºC. Presence of spirals was checked via dark field microscopy for all cultures.
Cultures were diluted in M1D at a 1:10 or 1:100 dilution prior to inoculation. For ID inoculation
routes, 2 mLs of SMCA was spun at 16000xg for 1 hour. The supernatant was discarded and the
pellet was re-suspended in 20 µL of M1D. For concentrated SMCA experiments, a stock of
SMCA was grown to equal 100 mL and frozen in 20 mL aliquots. At time of inoculation, 20 mL
were separated into 1 mL aliquots and spun at 16000xg for 1 hour. The supernatant was
removed from each tube and the pellet was re-suspended in PBS. All 20 tubes were combined to
equal 2 mLs. For heat-killed concentrated SMCA inoculums, the re-suspended 2 mL PBS
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culture was heated at 56oC in a water bath for 1 hour. To check sterility, 100 µL of heat killed
SMCA cultures were inoculated into 900 µL of fresh M1D and incubated for 14 days at 30ºC to
check for any viable organisms prior to inoculation into animals.
Animals: White tailed deer were chosen from the LSU AgCenter Idlewild Experiment Station.
Goats were obtained from the LSU AgCenter BenHur Research herd. All studies were done
according to protocols approved by the Louisiana State University Agricultural Center
Institutional Animal Care and Use Committee. Experimental animals were housed on concrete
slabs in an IBRDSC approved isolation research facility. Control deer were housed at the LSU
AgCenter Idlewild Experiment Station.
Tissue Samples:
Blood Samples: Jugular blood samples were collected and immediately stored in both EDTA
coated tubes and serum collection tubes. 100 μL of EDTA mixed blood was then transferred
to 900 μL of M1D and allowed to incubate at 30ºC for at least 21 days. Non-additive
samples were centrifuged at 400 RPMs for 10 minutes to separate serum. Serum was
removed and stored at -20ºC for immunoblotting.
Brain Tissues: At time of necropsy, heads were separated immediately and the brain was
removed using a stryker saw. The right half of the brain was immersed in 10% formalin and
stored at room temperature. After two weeks, samples were taken from the cortex,
hypothalamus, thalamus, hippocampus, cerebellum, midbrain, pons, obex, and spinal cord for
histological processing. The cortex, hypothalamus, and cerebellum were sampled for
culturing from the left half of the brain in both M1D and embryonated eggs. Samples were
also taken for PCR. The remaining left half of the brain was frozen at -80ºC.
Histology: Formalin-fixed sections were stained with haematoxylin and eosin. Using standard
protocols, the following immunohistochemical stains were applied: Anti-SMCA staining as
established by Bastian (Bastian et al., 2007) to detect presence of the organism; and glial
fibrillary acidic protein (GFAP) to detect the presence of astrogliosis.
Dark Field Microscopy: 5 µL of test sample was placed on a clean glass microscope slide,
mounted with a #1.5 cover slip and sealed on all 4 sides with clear finger nail polish. Slides
were examined with a Ziess Axio Imager A1 microscope (Carl Zeiss, Inc. North America,
Thornwood, NY, USA) equipped with a dark-field top lens condenser 1.2-1.4 and an EC PalnNeoFluar x100 oil immersion objective (Carl Zeiss, Inc. North America, Thornwood, NY, USA)
with 1.3 iris closed to its lowest setting (0.7).
Embryonated Egg cultures: Approximately 100 mg of tissue was taken from the cortex,
hypothalamus, and cerebellum and homogenized in 1 mL of M1D with 10 mg of vancomycin.
Cultures were spun at 1000 RPM for 5 minutes to remove tissue debris. The supernatant was
removed, and 10 μL was inoculated into the yolk sac of 7 day old embryonated eggs via a 1½
inch 22 gauge needle. Like number of eggs were injected with M1D media alone to serve as
controls. Eggs were candled daily to monitor viability. At death or time of harvest, allantoic
fluid was collected by aspiration via 1 inch 20 gauge needle and 3 ml syringe. The fluid was
observed via dark field microscopy for spiral organisms. 10 μL of allantoic fluid was passaged

68

back into 7 day old embryonated eggs as well as M1D. Second passage of eggs followed above
protocol; M1D was monitored for a color change until 21 days.
M1D cultures: Approximately 100 mg of tissue was homogenized in 1 mL of M1D with 10 mg
of vancomycin. Cultures were spun at 1000 RPM for 5 minutes to remove large chunks of tissue
debris. The top half of culture (500 μL) was removed and combined with fresh M1D with
vancomycin to 1 mL. M1D with vancomycin was added to the original homogenized tissue
culture to 1 mL. Cultures as well as a media control were incubated at either 30ºC or 37ºC,
dependent on the experiment, for at least 21 days. At 21 days, cultures were checked via dark
field microscopy for presence of spiral organisms. All cultures were also checked by PCR for
presence of SMCA organisms. Cultures were passaged at least once at a 1:100 dilution into
fresh M1D with vancomycin. Second passages were checked for spiral organisms via dark field
microscopy and PCR at 21 days as well.
PCR Methods: PCR was carried out using oligonucleotide primers that specifically aplified a
1460 bp portion of the S. mirum-related adhesin gene. The forward and reverse primers were F3
(5’-TCTAGTCTTAATCATTTTACTTATTTATTAGAA -3’) and R4 (5’TTATTAAGTCATTCACTCTCTTTCTTT -3’) respectively.
The reaction mixture (50 µL total) contained 2 µL of each the forward and reverse primers (10
µM each), 1 unit (0.2 µL) of Taq DNA Polymerase (New England BioLabs, Ipswich, MA), 2 µL
of 10 mM dNTP (AmpliTaq Gold, Applied Biosystems, Foster City, CA), and 5 µL of 10x
Standard Taq Buffer (New England BioLabs), which contains 15 mM of MgCl2. For M1D
cultures, 2 μL of culture was added to the reaction mixture without prior DNA extraction. DNA
extraction followed the QIAamp Blood and Tissue DNA Extraction protocol for all animal tissue
PCR reactions. Each reaction was brought to a final volume of 50 μL with sterile, nuclease-free
H2O. PCR’s were performed using a MyCycler Thermal Cycler (Bio-rad). The thermal cycler
program used was 94ºC for 5 minutes, then 30 cycles at 94ºC for 30 seconds, 57ºC for 20
seconds, and 72ºC for 120 seconds followed by a final extension of 72ºC for 10 minutes. All
PCR products were electrophoresed on a 1% agarose gel in Tris-acetate-EDTA (TAE) buffer,
and the DNA was visualized by SYBR Safe (Invitrogen, Eugene, OR) DNA gel staining under
UV fluorescence.
Western Blots: SMCA cell lysates were made as 3 different antigen preparations: boiled,
guanidine thiocyanate, and sonicated. The boiled SMCA antigen preparation was made as
follows. Six 1 mL aliquots of SMCA were spun at 16000xg for 1 hour. Supernatant was
discarded and 1 mL of PBS was added to each pellet. Each 1 mL suspension was then boiled for
10 minutes. All vials were mixed together to create a stock solution. Laemmli buffer with 2mercaptoethanol was added volume to volume to SMCA solution and boiled for ten minutes.
The guanidine thiocyanate-SMCA preparation was as described by Bastian (Bastian et al., 2004).
The preparation was made, and laemmli buffer with 2-mercaptoethanol was added to a like
amount and boiled for 10 minutes. The sonicated SMCA preparation was made following the
same procedures as the boiled preparation. However, after boiling for 10 minutes, each 1 mL
aliquot was then sonicated for 10 minutes (Heat-Systems-Ultrasonic, Inc., cycle time 1 sec; duty
cycle 50%). All vials were mixed together to create a stock solution and laemmli blue with 2mercaptoethanol was added as stated previously. All solutions were stored at -20ºC.
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In order to determine an antibody profile for SMCA, 2 goats were immunized with boiled SMCA
antigen. 1 mL of the solution was mixed with 1 mL of incomplete freund’s adjuvant. The 2 mL
mixture was injected intramuscularly into 2 different goats. Goats were boosted with 0.5 mL
SMCA and 0.5 mL incomplete freund’s adjuvant 4 and 6 weeks later. The same procedures
were followed for inoculation of 2 goats with the sonicated antigen preparation. Serum was
collected at various time points post-immunization and stored at -20ºC for future analysis.
Western immunoblot analysis was performed using the three cell lysates of SMCA.
Electrophoresis was performed with a BioRad Mini-Protean II unit (Hercules, California, USA)
utilizing the Laemmli discontinuous SDS-PAGE method with 5 μL of cell lysate per 20 μL well.
Nitrocellulose transfer was performed for one hour with 150V in a Mini Trans-Blot
Electrophoretic Transfer Cell (Bio-Rad). Following transfer the blots were blocked with a 5%
nonfat milk buffer for one hour followed by washing with tris-buffered saline containing 0.5%
Tween-20. Three adjoining membrane lanes containing the 3 cell lysates were then incubated
for at least 8 hours at 37ºC with a 1:40 dilution of the test serum. Subsequently, the blots were
washed and incubated with rabbit anti-bovine (deer studies) or anti-goat (goat and sheep studies)
IgG horseradish peroxidase conjugate (Sigma Chemical Company, Saint Louis, Missouri, USA)
at a dilution of 1:800 for 45 minutes at room temperature. After washing, the substrate 4-chloro1-naphthol (Sigma) was added for at least 10 minutes for color development.
Experiment 1
One neonatal goat was inoculated IC with 2 mLs of SMCA and a tracer. Twenty-four hours
post-inoculation, the goat was humanely euthanized and the skull was removed for gross
examination of the brain. The tracer was located in order to establish the area of inoculation in
vivo. Various tissue samples were cultured in M1D as described above. Samples were also
tested for presence of spiroplasma via PCR.
Experiment 2
Four, 5 month old deer were tranquilized with Telazol (2.5 mg/kg) and xylazine (0.3 mg/kg) via
a dart gun and inoculated through the open fontanel of the skull and into the left hemisphere with
2 mLs of SMCA via an 18 gauge needle. Four control deer of like age and genetics were
inoculated with 2 mLs of MID media in the same manner and remained at Idlewild. Deer were
observed daily and euthanized at time of clinical signs or 7 months post-inoculation. The control
deer were euthanized at the same time as the SMCA-inoculated deer for control tissues. Brain
and eye tissues were collected and processed as described above.
Experiment 3
Twenty-nine 1 month old goats were separated into the following groups: 12 SMCA-inoculated
goats, 3 SMCA 1:10 dilution goats, 2 SMCA 1:100 dilution goats, 6 M1D inoculated goats, 6
control goats. All inoculations equaled 2 mLs and were administered IC through the fontanel of
the skull. Goats were separated by sex and housed on concrete slab stalls. Jugular blood
samples were obtained every 6 months for immunoblotting. All animals were observed daily
and euthanized if exhibiting clinical signs or at 2 years. Brain and eye tissues were collected and
processed as described above.

70

Experiment 4
Twelve newborn goats were injected within 48 hours after birth via different inoculation routes
and allowed to remain with mother. Three newborns were injected with 2 mLs of SMCA via
the open fontanel of the skull; 5 were injected with 2 mLs of SMCA IV via the jugular vein; and
4 were injected with 0.2 mLs of concentrated SMCA with a 22 gauge needle ID on the lower
eyelid. A jugular blood sample was obtained daily for the first 7 days and then weekly. All were
housed on concrete slab stalls and observed daily for clinical signs. Goats were euthanized at
time of clinical signs or 2 months after inoculation. Brain and eye tissues were collected and
processed as described above.
Experiment 5
Three newborn goats were injected 48 hours after birth with concentrated SMCA (10X) via the
open fontanel of the skull and allowed to remain with mothers. Two newborns were injected in
similar manner with heat-killed concentrated SMCA. All goats were housed on concrete slab
stalls and observed daily for clinical signs. Goats were euthanized at time of clinical signs or 4
months after inoculation. Brain and eye tissues were collected and processed as described above.

Table 4.2 Summary of Experimental Animals
Exp
Species
Inoculum
Caprine
SMCA
1
Cervidae
SMCA
2
SMCA (IC)
Caprine
SMCA (IV)
3
SMCA (ID)
10x Concentrated SMCA
Caprine
4
Heat-killed 10x Concentrated SMCA
Caprine
SMCA
5

Length of Experiment
24 hours
6 months
2 months
4 months
2 years

Results
Experiment 1
Spiroplasma was recovered at high numbers from the mid-cerebral cortex adjacent to the area of
inoculation. Organisms were recovered from the optic nerve, cerebral cortex, hypothalamus,
thalamus, and hippocampus. Swabs of the skull cavity were positive for Spiroplasma, providing
evidence that the inoculum pools within the brain cavity sufficiently soaking all areas of brain
tissue. No organisms were found in homogenized cultures of cerebellum, midbrain, pons, obex,
or spinal chord. PCR results were the same as culture results. Figure 4.1 depicts the areas of
spiroplasma recovery in this experiment.
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Inoculation Site
+
+++
+
-

Figure 4.1 Spiroplasma recovery 24 hours post-inoculation. Positive areas are
indicated by +, negative areas are indicated by -.

Experiment 2-5
Clinical Signs: Prior to necropsy seven months post-inoculation, one deer showed minimal
clinical signs (lethargy and slight weight loss). No goats exhibited any clinical signs regardless
of experiment duration, inoculation route or dosage.
Histology: After extensive review, none of the experimentally infected animals appeared to have
any pathological changes. No abnormalities were seen in H&E staining and no sections were
positive for anti-SMCA antibody staining. One deer was positive for GFAP staining, however, it
had been inoculated with M1D only (Figure 4.2 A). A comparison of SMCA-inoculated deer is
seen in Figure 4.2 B.
Persistence of SMCA:
Blood: SMCA was recovered from the blood of neonatal goats IC and IV inoculated four days
post inoculation. The bacteria could not be recovered after five days post inoculation. No
organisms were recovered via the blood from any ID inoculated goats. PCR was conducted on
all cultures to confirm presence of organisms.
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A

B

Figure 4.2 GFAP staining of experimental animals
A) GFAP staining from a M1D-inoculated deer six months post inoculation.
B) GFAP staining from a SMCA-inoculated deer six months post inoculation.

M M 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18
19 20

Figure 4.3 PCR results demonstrating cultures positive for SMCA. Lanes 1-3: IC goat cultures
(14 days post-inoculation), Lanes 4-6: IV goat cultures (2 days post-inoculation), Lanes 7-9: ID
goat cultures (2 days post-inoculation), Lanes 10-11: IC goat cultures (3 days post inoculation),
Lane 12: water negative, Lanes 13-14: positive controls, Lanes 15-18: IV goats (4 days post
inoculation). PCR primers are specific to the S. mirum adhesin gene.
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Brain Tissues:
We were able to recover SMCA from one out of fifty-four animals. The cortex from an SMCA
IC inoculated deer in experiment two was positive for spiroplasma organisms. The tissue was
homogenized in M1D, and the supernatant inoculated into four embryonated eggs. Pooled
allantoic samples were taken and inoculated into M1D media. After two passages in M1D, one
helical organism was noticed via dark field microscopy (Figure 4.4). The culture was passaged
into fresh M1D, but no Spiroplasma growth was found after any passages (M1D) or any
embryonated eggs cultures that followed.

Figure 4.4 Spiroplasma seen via dark field microscopy from SMCA-inoculated deer.

PCR: No tissue samples from any of the fifty-four experimental animals tested were positive for
spiroplasma via PCR. Figure 4.5 is an example PCR blot from SMCA-inoculated tissues. The
positive banding seen is from the positive control. All other samples were negative.

Figure 4.5 PCR for SMCA-inoculated tissues. PCR primers are specific to the S. mirum adhesin
gene.
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Antibody Production: Multiple serum samples were tested from each animal inoculated with
SMCA. For short term experiments, serum samples from six weeks and eight weeks were tested.
For long term experiments, serum samples were taken at six weeks and then once every six
months. There was no spiroplasma-specific banding on any immunoblots for SMCA antibodies.
There were minor non-specific bands found on SMCA-inoculated animals as well as M1Dinoculated animals. The antibody profiles from a goat hyperimmunized with boiled SMCA
antigen can be seen in Figure 4.6 C below. Figure 4.6 A is an example of a western blot from a
M1D-inoculated goat and B is from an SMCA-inoculated animal.

C
A
B
Figure 4.6 Immunoblots from experimental animals
A) Immunoblot from M1D-inoculated animal, B) Immunoblot from SMCA-inoculated animal.,
C) Immunoblot from goat hyperimmunized with boiled SMCA antigen.
The first line in all blots is the marker, the second line is the boiled antigen preparation, the third
line is the guanidine thiocyanate-SMCA preparation. The last line is a from a Yesinia antigen
preparation, used as a positive control.

Discussion
For the purpose of discussion, we will include all ruminant experiments done in this laboratory.
This will include the experiments published by Bastian et al. in 2007 (Bastian et al., 2007).
Table 4.3 summarizes all ruminant experiments. Figure 4.7 depicts an overall timeline for
SMCA ruminant experiments.
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Table 4.3 Summary of ruminant experiments
Exp
Species
Inoculum
Bastian
Cervidae
SMCA
2007
Cervidae
SMCA
2
SMCA
Ovis
1:10 SMCA
Bastian
2007
1:100 SMCA
Caprine
SMCA
SMCA (IC)
Caprine
SMCA (IV)
3
SMCA (ID)
10x Concentrated SMCA
Caprine
4
Heat-killed 10x Concentrated SMCA
Caprine
SMCA
5

Length of Experiment
6 months
6 months
1.5 years
4 months
2 months
4 months
2 years

Figure 4.7 An overall timeline for SMCA ruminant experiments.
The experiments in this paper did not result in any evidence of pathology or persistence of
SMCA. None of the fifty-four experimental animals were positive for spongiform
encephalopathy, and only one was positive for the organism after six months of incubation.
Tully suggested that pathogenicity is dependent on the S. mirum strain, the animal host, and the
history of the inoculum (Tully et al., 1983). In the case of SMCA, after continued passage on
artificial media, the LD50 for suckling rats increased; and the strain no longer induced cataracts,
while the LD50 for chick embryos decreased (Bove, 1997). Loss of pathogenicity due to multiple
passages could be an explanation for the contrasting results found in our experiments compared
to those from 2007 (Bastian et al., 2007) however, virulence was seen in embryonated egg
experiments previously reported in this body of work.
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Clark found that SMCA pathology was dependent on dose, age, and host strain (Clark and
Karson, 1968). This may account for the differences seen in deer experiments since our deer
were five months old at time of inoculation. Clark also found that the larger the dose and the
younger the host the greater pathology produced (Clark and Karson, 1968). This did not hold
true in our neonatal goat experiments where we inoculated ten times the normal inoculum within
seventy-two hours of birth. In 1984 Bastian reported microcystic encephalitis in rats one day
after intracranial inoculation of GT48. The same experimental group of rats had minimal
pathological alterations at day twenty-five (Bastian et al., 1984). Spiroplasma was still recovered
in these tissues, but no pathology was associated in this experiment. These results could suggest
that there is a transition time for pathology in different species. However, we tested goats at two
months, four months, and two years and no pathology was detected at any time point.
For spiroplasma experiments and prion research, bacteria/prion strain has played a role in
susceptibility. Mice strains also played a role in susceptibility. Our neonatal experiments were
conducted using animals from the same genetic pool. One could argue that these strains have
resistance to our organisms; however, Bastian’s experiments resulted in pathology and the
current study did not. Experiments using tissues from 2007 animals found no persistence of the
organisms in brain tissues or production of antibodies at any time (data not published) which
concurs with the present studies.
Spiroplasma was recovered from one experimentally infected animal. The results from
experiment 1 (24 hour neonatal goat experiment) were used to determine the concentrations in
certain areas for best options for organism recovery. Although spiroplasma was recovered from
these areas in this experiment, the organism may migrate to different areas over time. In
reported mice experiments, the maximal SMCA titer attained in the brain was at day fifteen post
intracerebral inoculation. SMCA was recovered from blood of mice eighteen days post
inoculation. No organisms were recovered after twenty-one days. Research found that the titer
was always higher in the brain compared to blood (Clark, 1969). Titers peaked at day fifteen in
brain tissues and subsequently decreased very slowly, with minimal titers of SMCA in mice
sacrificed at after 800 days post inoculation (Clark and Karson, 1968). In experiments using
other inoculation routes, no persistence of the organism was noted. One researcher has
suggested that the failure to observe spiroplasma-like bodies in infected brains suggests that the
site of localization of the infection has not yet been ascertained, or less likely but more
intriguing, that the agent may be present in an unrecognizable form within the central nervous
tissue (Clark, 1974).
SMCA was able to avoid the immune system resulting in a lack of antibody production in
experimental animals. Immunoblots with three different SMCA antigen presentations were
unable to detect any antibody from any time points in the experiments. In his 1984 rat
experiments, Bastian (Bastian et al., 1984) also found a lack of antibody production and
suggested that the presence of spiroplasma in the tissues without inflammatory response could be
indicative of a unique adaptation of the organism to the host. This peculiar host adaptation may
be related to the intracellular localization of the organisms. Clark did find evidence of antibody
production in his mice experiments in 1968. Dams infected while pregnant did not transfer
SMCA to their offspring (Clark and Karzon, 1968). The mothers were, however, able to transfer
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protective antibodies to their offspring, who never developed cataracts post- intracerebral
inoculation. Furthermore, following generations were able to pass protection to their offspring
and prevent disease. The same experiments were repeated and found to hold true with GT48
(Clark and Karzon, 1968).
Spiroplasma mirum has only been isolated naturally from the rabbit tick. The true pathogenicity
has been questioned since the organism has only experimentally induced disease either by
inoculation into the yolk sac of seven day old chick embryos; intracerebral injection into
newborn rats, mice or hamsters; or by inoculation into scarified cornea of adult rabbits (Bove,
1997). The fastidious nature of the organism makes primary isolation challenging and leaves
researchers questioning other possible hosts. In these experiments different inoculation routes
were tested in order to prove a hematogenous transmission route. No changes were seen within
these experimental animals. In 1987 Bastian induced cataracts, weight reduction, and alopecia in
rats with GT48 inoculated intraperitoneal or subcutaneously. The organism was recovered at
low titers fifty days post inoculation. The brains of rats evaluated at day fifty showed minimal
neuronal vacuolization in the hippocampus region. The peripheral route of inoculation failed to
produce the moribund state and vacuolar encephalopathy shown when suckling rats were
inoculated intracerebrally with spiroplasma (Bastian et al., 1987b). These findings do not
support a hematogenous transmission route which would be needed for transmission from a tick
to an animal.
Conclusion
The results reported in this chapter establish that the inoculation of this laboratory’s S. mirum
strain SMCA into neonatal goats did not mimic the clinical signs or pathology seen in
transmissible spongiform encephalopathies. SMCA did not cause spongiform encephalopathy
when inoculated intracerebrally, intravenous, or intradermally into neonatal goats. No
pathology, clinical signs, or immune responses were noted over a two year time period; and the
organism was not detected via PCR or culture from any experimentally inoculated animals.
When inoculated into five month old white-tailed deer, SMCA did cause minimal clinical signs
in one animal but did not cause spongiform encephalopathy after seven months. Spiroplasma
was recovered from the cortex of the clinically-affected deer after multiple passages in culture.
Although the goat experiments in this chapter did not result in TSE-like disease, the
methodology has been established for an animal model. Further research should be conducted
using similar methods in neonatal white-tailed deer to better compare CWD and deer
spiroplasmosis. Experiments using sheep may also allow for better comparisons to scrapie.
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CONCLUSION
There have been many contradicting reports in the literature involving the culturing of S. mirum,
its resistance to disinfectants and antibiotics, and its role in Transmissible Spongiform
Encephalopathy (TSE). These discrepancies led to the interest in a possible connection between
spiroplasma and TSEs and the development of the research in this document. Based on the
results reported by Bastian et al. in 2007, it was hypothesized that Spiroplasma was associated
with a neurodegenerative disease such as TSE. In this work we further characterized S. mirum
and continued to evaluate the possible correlations found in TSE infections. In order to establish
the best overall picture of S. mirum infections, we optimized culture conditions, determined a
susceptibility profile for physical and environmental disinfectants and anitbiotics, and improved
the methodology for creating an animal model for spiroplasmosis. From this information, a
better comparison may be made to the presumed infectious agent of TSEs, the prion.
To optimize recovery of S. mirum from experimental infections, we established reproducible
culture conditions in M1D media, embryonated eggs, and SP4 plates in chapter two. Growth in
M1D media at 30°C proved to be significantly better (p<0.05), yielding higher dark field counts
than cultures at 37°C. Dark field enumeration appears to be limited to a range of 1x105 to 1x108
organisms/mL and therefore an accurate growth curve could not be calculated using this method.
PCR was used to check for growth daily and results were comparable to dark field counts. Color
changes were evident in all dilutions after 7 days, though the more diluted cultures were less
obvious. Embryonated egg results were comparable to that in the literature; however, the
artificial media is better for experimental purposes. The organism is difficult to detect after egg
fatality by both dark field and PCR. PCR results may be skewed due to inhibitory factors in the
egg fluids. Embryonated egg experiments support that the laboratory strains were not attenuated
by multiple passages and still produce similar virulence in embryonated egg cultures as seen in
literature. A method for obtaining colony forming units was also determined for SMCA and
GT48. Following the ATCC SP4 recipe with the addition of Noble agar (1.6%), S. mirum
produced consistent countable colonies on or near the surface of the agar. Those plates incubated
at 37°C yielded higher growth counts and significantly better growth (p<0.05) than those at
30°C.
Because of the organism’s fastidious nature, tissue culture may be more appropriate for
spiroplasma research. Attempts have been made to cultivate S. mirum in a variety of
mammalian, avian and tick cell cultures, but these were unsuccessful due to cytopathic effects
and slow growth of the organism (Bastardo et al., 1974; Clark, 1964; Fabiyi et al., 1971; Yunker
et al., 1987). SMCA has also been found to permanently transform NIH 3T3 mouse embryo
fibroblast cells (Bove, 1997; Kotani et al., 1986). SMCA also transformed monkey kidney CV-1
cells (Kotani et al., 1986). Due to the formation of cataracts in suckling mice, Megraud et al.
experimented with the affinity the organism showed for ocular tissues (Megraud et al., 1983).
Even though some research has been promising, successful tissue cultures have yet to be
established. Although no tissue culture experiments were conducted in this body of work, the
establishment of a tissue culture system may better elucidate the organism’s potential hosts and
pathogenic nature.
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Chapter three establishes a susceptibility profile for disinfectants and antibiotics and compares
these results to known prion susceptibility. Although Spiroplasma and prions may persist in
murine neurologic tissues for a long period of time, the two do not share the same properties of
resistance. The three species of Spiroplasma tested were susceptible to minimal dilutions of
common laboratory disinfectants. They were also susceptible to many of the antibiotics in use
for other mollicutes. We did find strain differences in S. mirum in that GT48 was more resistant
than SMCA to many of the disinfectants and antibiotics tested. More research is needed to
determine the factors it may possess in order to achieve this resistance.
The animal experiment results reported in chapter four establishes that the inoculation of this
laboratory’s S. mirum strain SMCA into neonatal goats did not mimic the clinical signs or
pathology seen in TSEs. SMCA did not cause spongiform encephalopathy when inoculated
intracerebrally, intravenous, or intradermally into neonatal goats. No pathology, clinical signs,
or immune responses were noted over a two year time period; and the organism was not detected
via PCR or culture from any experimentally inoculated animals. When inoculated into five
month old white-tailed deer, SMCA did cause minimal clinical signs in one animal but did not
cause spongiform encephalopathy after seven months. Spiroplasma was recovered from the
cortex of the clinically-affected deer after multiple passages in culture. The tissue was
homogenized in M1D and the supernatant inoculated into four embryonated eggs. Pooled
allantoic samples were taken and inoculated into M1D media. After two passages in M1D, one
helical organism was noticed via dark field microscopy. The culture was passaged into fresh
M1D, but no growth was found after any passages (M1D or embryonated eggs).
Tully suggested that pathogenicity is dependent on the S. mirum strain, the animal host, and the
history of the inoculum (Tully et al., 1983). Loss of pathogenicity due to multiple passages could
be an explanation for the contrasting results found in our experiments compared to those from
2007 (Bastian et al., 2007); however, virulence was seen in embryonated egg experiments. Clark
found that SMCA pathology was dependent on dose, age, and host strain (Clark and Karson,
1968). This may account for the differences seen in deer experiments since our deer were five
months old at time of inoculation. Clark also found that the larger the dose and the younger the
host the greater pathology produced (Clark and Karson, 1968). This did not hold true in our
neonatal goat experiments where we inoculated ten times the normal inoculum within seventytwo hours of birth. Although the goat experiments in this chapter did not result in TSE-like
disease, the methodology has been established for an animal model. Further research should be
conducted using similar methods in neonatal white-tailed deer.
Spiroplasma mirum’s growth at both 30oC and 37oC may suggest the possibility for two hosts.
Research on S. citri has established its ability to survive in multiple hosts. At least two
mechanisms are utilized for sugar uptake by S. citri: the
phosphoenolpyruvate:phosphotransferase system (PTS) and the SBP-ABC transporter system
(Bai and Hogenhout, 2002; Gaurivaud et al., 2000b). This could be characteristic of multiplehost bacteria that need to rapidly adapt from a host or host-compartment that uses one sugar to a
host or host-compartment that uses a different sugar (Bove et al., 2003). As more spiroplasma
genomes are completed, a better understanding of these organisms’ ability to utilize different
substrates in their environment will be obtained, which may determine the different hosts the
organisms may inhabit. Spiroplasma citri’s use of the PTS system may also allow this organism
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to create a biofilm (Bove et al., 2003). The creation of a biofilm may affect the virulence of this
organism and may be the reason Spiroplasma is so difficult to recover from tissues. More
research is needed to establish that Spiroplasmas create biofilms and what changes in resistance
this could create.
Other strains of spiroplasma may also have the potential to cause neurodegenerative disease.
Spiroplasma melliferum has also been shown to persist in suckling mice post intracerebral
inoculation. Only one mouse exhibited CNS-like signs, and the organism was only isolated from
one experimentally infected mouse after 284 days (not the clinical one). Spiroplasma melliferum
was isolated at day seventy at a rate of 107 to 1010 CCU/ml in brain titers. These titers were lost
after repeated passages in suckling mice. No neurological signs were observed, and histological
changes were limited to discrete diffuse capillary congestion in brain sections. There was no
antibody response from the suckling mice to S. melliferum, as is the case for S. mirum (Chastel et
al., 1991). Leafhoppers infected with S. citri (Western-X disease) develop lesions, notably in the
optic lobes and salivary glands (Nasu et al., 1970; Whitcomb et al., 1967). Simultaneous
involvement of the optic lobes and salivary glands in Western-X has similarity to the occurrence
of either Sjorgren’s syndrome or mucosal inflammation with ocular manifestations in Multiple
Sclerosis (MS) (Coyle and Bulbank, 1989; Sandberg-Wollheim et al., 1992). Brown suggested
that the infection of both plant phloem and insect axons suggests a predilection of the organism
for components of electrochemical conduction (Brown, 2003). Clinical correlations have been
made with bee and wasp stings and the subsequent development of MS (Dionne et al., 2000).
These reports attribute the disease to bee venom; but bees and wasps are known carriers of
spiroplasmas, and Brown suggests that the inoculation of humans with S. citri by bee or wasp
stings could be the mechanism causing MS (Brown, 2003). Using the methodology for an
animal model set forth in chapter four, further research with these spiroplasma strains may
provide insight into their potential association with neurodegenerative diseases.
Clark suggested that the SMCA system could provide a useful model for the study of intraocular
infection (Clark, 1969). Bastian has isolated Spiroplasma from ocular fluid taken aseptically
from scrapie-infected sheep. Minced corneal tissues were inoculated into M1D, and
Spiroplasma organisms were evident via dark field microscopy. These organisms did not
propagate and the culture was lost after several passages (Bastian et al., 2011). This has recently
been repeated and efforts are ongoing to passage the spiroplasma to a substantial culture (data
not published). There has been evidence in the literature that mycoplasma-like organisms were
isolated from the aqueous humors of eleven of nineteen human eyes with unexplained uveitis
(Zeigel and Clark, 1974) and S. mirum may be a causative agent of uveitis in ruminants. Its
affinity for ocular tissue has been established, and more research is needed in unexplained uveitis
cases in order to prove this association.
Based on the experiments performed in this body of work, further research should be conducted
with S. mirum. The genomes of multiple strains of spiroplasma are presently being determined
(Landry et al., 2010). Optimal growth characteristics have been established, and research can
now move into genetic manipulations to evaluate possible virulence factors for spiroplasma.
With the organism’s affinity for neurologic and ocular tissues, spiroplasma could be genetically
manipulated to be used as a potential therapeutic agent for infections affecting these tissues.
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